HGK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S22 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | SKSEsPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTD |
| A0A2R8Y4L2 | T25 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | EsPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTDCVV |
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| O00151 | T78 | Sugiyama | PDLIM1 CLIM1 CLP36 | TSNMTHLEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGK |
| O00151 | T80 | Sugiyama | PDLIM1 CLIM1 CLP36 | NMTHLEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGKRH |
| O00203 | T424 | Sugiyama | AP3B1 ADTB3A | TLLREFQTYVKSQDKQFAAAtIQtIGRCATNILEVTDTCLN |
| O00203 | T427 | Sugiyama | AP3B1 ADTB3A | REFQTYVKSQDKQFAAAtIQtIGRCATNILEVTDTCLNGLV |
| O00303 | T119 | Sugiyama | EIF3F EIF3S5 | LASIVDSYERRNEGAARVIGtLLGtVDKHSVEVTNCFSVPH |
| O00303 | T123 | Sugiyama | EIF3F EIF3S5 | VDSYERRNEGAARVIGtLLGtVDKHSVEVTNCFSVPHNEsE |
| O00567 | S151 | Sugiyama | NOP56 NOL5A | NLVKGLTDLSACKAQLGLGHsYSRAKVKFNVNRVDNMIIQS |
| O14818 | T147 | Sugiyama | PSMA7 HSPC | FGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKS |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14920 | S177 | EPSD | IKBKB IKKB | EQRLIHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQ |
| O14920 | S181 | EPSD | IKBKB IKKB | IHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQKyTV |
| O15067 | S1053 | Sugiyama | PFAS KIAA0361 | RGLRERMGPSYCLPPTFPKAsVPREPGGPsPRVAILREEGS |
| O15111 | S176 | EPSD | CHUK IKKA TCF16 | GGKIIHKIIDLGYAKDVDQGsLCTsFVGTLQYLAPELFENK |
| O15111 | S180 | EPSD | CHUK IKKA TCF16 | IHKIIDLGYAKDVDQGsLCTsFVGTLQYLAPELFENKPYTA |
| O15143 | S323 | Sugiyama | ARPC1B ARC41 | QNLDKKAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCS |
| O15212 | T107 | Sugiyama | PFDN6 HKE2 PFD6 | IKRYESQLRDLERQsEQQREtLAQLQQEFQRAQAAKAGAPG |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O43252 | T612 | Sugiyama | PAPSS1 ATPSK1 PAPSS | RKLAREGQKPPEGFMAPKAWtVLtEyyKSLEKA________ |
| O43252 | T615 | Sugiyama | PAPSS1 ATPSK1 PAPSS | AREGQKPPEGFMAPKAWtVLtEyyKSLEKA___________ |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43390 | T142 | Sugiyama | HNRNPR HNRPR | PDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQPG |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43615 | T198 | Sugiyama | TIMM44 MIMT44 TIM44 | ALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKF |
| O43707 | S507 | Sugiyama | ACTN4 | DsHNVNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAID |
| O43707 | T359 | Sugiyama | ACTN4 | RRVHKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKM |
| O43707 | T362 | Sugiyama | ACTN4 | HKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKMVSD |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43707 | T509 | Sugiyama | ACTN4 | HNVNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAIDQL |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60361 | T88 | Sugiyama | NME2P1 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60506 | T139 | Sugiyama | SYNCRIP HNRPQ NSAP1 | PDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQPs |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60716 | S230 | Sugiyama | CTNND1 KIAA0384 | PDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGyRA |
| O60716 | T869 | Sugiyama | CTNND1 KIAA0384 | FQVNLNNAsRsQssHsyDDstLPLIDRNQKsDKKPDREEIQ |
| O60763 | T22 | Sugiyama | USO1 VDP | NFLRGVMGGQSAGPQHTEAEtIQKLCDRVAssTLLDDRRNA |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O60841 | S222 | Sugiyama | EIF5B IF2 KIAA0741 | KNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAEKKERERKK |
| O75122 | S1027 | Sugiyama | CLASP2 KIAA0627 | sMPtHssPRsRDyNPyNysDsIsPFNKsALKEAMFDDDADQ |
| O75390 | T335 | Sugiyama | CS | LQKEVGKDVSDEKLRDYIWNtLNSGRVVPGyGHAVLRKTDP |
| O75533 | T203 | Sugiyama | SF3B1 SAP155 | VVNGAAAsQPPsKRKRRWDQtADQtPGAtPKKLssWDQAEt |
| O75821 | T206 | Sugiyama | EIF3G EIF3S4 | LGLstGEKEKLPGELEPVQAtQNKtGKYVPPsLRDGAsRRG |
| O75821 | T210 | Sugiyama | EIF3G EIF3S4 | tGEKEKLPGELEPVQAtQNKtGKYVPPsLRDGAsRRGESMQ |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O94776 | S433 | Sugiyama | MTA2 MTA1L1 PID | ATRGtTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQt |
| O94776 | T417 | Sugiyama | MTA2 MTA1L1 PID | YWKKYGGLKtPTQLEGATRGtTEPHSRGHLsRPEAQsLsPy |
| O94776 | Y437 | Sugiyama | MTA2 MTA1L1 PID | tTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFLLQ |
| O94826 | S110 | Sugiyama | TOMM70 KIAA0719 TOM70 TOMM70A | AsPAPGsGHPEGPGAHLDMNsLDRAQAAKNKGNKYFKAGKY |
| O95071 | T119 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | GRTSRPGRTSDsPWFLsGSEtLGRLAGNTLGSRWSsGVGGs |
| O95721 | T137 | Sugiyama | SNAP29 | GGLVNYFKSKPVEtPPEQNGtLtSQPNNRLKEAISTSKEQE |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| O95834 | T350 | Sugiyama | EML2 EMAP2 EMAPL2 | EVEVPEDFGPVRTVAEGHGDtLyVGtTRNSILQGSVHTGFS |
| O95834 | T355 | Sugiyama | EML2 EMAP2 EMAPL2 | EDFGPVRTVAEGHGDtLyVGtTRNSILQGSVHTGFSLLVQG |
| O95835 | T1079 | PSP | LATS1 WARTS | DtLNGWYKNGKHPEHAFYEFtFRRFFDDNGYPYNYPKPIEY |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | T275 | Sugiyama | LDHA PIG19 | SVADLAESIMKNLRRVHPVstMIKGLYGIKDDVFLSVPCIL |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P02545 | T519 | Sugiyama | LMNA LMN1 | AAGAGAtHsPPTDLVWKAQNtWGCGNsLRtALINstGEEVA |
| P02786 | T336 | Sugiyama | TFRC | FNHTQFPPSRSSGLPNIPVQtISRAAAEKLFGNMEGDCPSD |
| P04040 | S517 | Sugiyama | CAT | LDKYNAEKPKNAIHtFVQsGsHLAAREKANL__________ |
| P04040 | T125 | Sugiyama | CAT | KKTPIAVRFStVAGEsGSADtVRDPRGFAVKFYTEDGNWDL |
| P04040 | T434 | Sugiyama | CAT | QQPSALEHSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEE |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T119 | Sugiyama | ALDOA ALDA | KsKGGVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYK |
| P04075 | T123 | Sugiyama | ALDOA ALDA | GVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGA |
| P04083 | S182 | Sugiyama | ANXA1 ANX1 LPC1 | RDLAKDItsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsD |
| P04150 | T519 | PSP | NR3C1 GRL | GIQQATTGVsQETSENPGNKtIVPAtLPQLTPTLVSLLEVI |
| P04150 | T562 | PSP | NR3C1 GRL | EVLYAGYDSSVPDStWRIMTtLNMLGGRQVIAAVKWAKAIP |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | T185 | Sugiyama | ALPP PLAP | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQEGC |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05783 | T404 | Sugiyama | KRT18 CYK18 PIG46 | LEDGEDFNLGDALDssNsMQtIQKtTTRRIVDGKVVsETND |
| P05783 | T408 | Sugiyama | KRT18 CYK18 PIG46 | EDFNLGDALDssNsMQtIQKtTTRRIVDGKVVsETNDtKVL |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06733 | S14 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | _______MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAA |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06744 | T250 | Sugiyama | GPI | LQAAKDPSAVAKHFVALstNttKVKEFGIDPQNMFEFWDWV |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P06748 | S43 | Sugiyama | NPM1 NPM | LKADKDyHFKVDNDENEHQLsLRTVsLGAGAKDELHIVEAE |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T18 | Sugiyama | LDHB | ___MATLKEKLIAPVAEEEAtVPNNKITVVGVGQVGMACAI |
| P07195 | T276 | Sugiyama | LDHB | SVADLIESMLKNLSRIHPVStMVKGMYGIENEVFLSLPCIL |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07711 | T332 | Sugiyama | CTSL CTSL1 | VKMAKDRRNHCGIAsAAsyPtV___________________ |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | T745 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVR |
| P07858 | T218 | Sugiyama | CTSB CPSB | CTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSEKD |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S169 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILH |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | S72 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ssDALDKIRyEsLtDPsKLDsGKELHINLIPNKQDRtLtIV |
| P07900 | T109 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LtIVDtGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P07900 | T467 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKEN |
| P07900 | T624 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIE |
| P07900 | T88 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | sKLDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| P07900 | T90 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLGtI |
| P08195 | T321 | Sugiyama | SLC3A2 MDU1 | SIRVILDLTPNYRGENSWFStQVDtVATKVKDALEFWLQAG |
| P08195 | T325 | Sugiyama | SLC3A2 MDU1 | ILDLTPNYRGENSWFStQVDtVATKVKDALEFWLQAGVDGF |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S164 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILH |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | S67 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AsDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERtLtLV |
| P08238 | T104 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LtLVDtGIGMtKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P08238 | T459 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEt |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T616 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVE |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | T83 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sKLDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLG |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08708 | T30 | Sugiyama | RPS17 RPS17L | KKAARVIIEKyytRLGNDFHtNKRVCEEIAIIPSKKLRNKI |
| P08758 | S37 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ERADAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAF |
| P08758 | T40 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | DAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTL |
| P08758 | T43 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | tLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTLFGR |
| P08865 | T94 | Sugiyama | RPSA LAMBR LAMR1 | VsVIssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQA |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09211 | T68 | Sugiyama | GSTP1 FAEES3 GST3 | CLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQQEAA |
| P09234 | T11 | Sugiyama | SNRPC | __________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHK |
| P09234 | T14 | Sugiyama | SNRPC | _______MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKENV |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09651 | S22 | Sugiyama | HNRNPA1 HNRPA1 | sKsEsPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTD |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09651 | T25 | Sugiyama | HNRNPA1 HNRPA1 | EsPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTDCVV |
| P09923 | T182 | Sugiyama | ALPI | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQEGC |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P0DPH7 | T41 | Sugiyama | TUBA3C TUBA2 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P10412 | T96 | Sugiyama | H1-4 H1F4 HIST1H1E | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P10809 | T113 | Sugiyama | HSPD1 HSP60 | IGAKLVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISK |
| P10809 | T173 | Sugiyama | HSPD1 HSP60 | AELKKQsKPVttPEEIAQVAtIsANGDKEIGNIIsDAMKKV |
| P10809 | T478 | Sugiyama | HSPD1 HSP60 | NEDQKIGIEIIKRTLKIPAMtIAKNAGVEGsLIVEKIMQSS |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T586 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DKQKILDKCNEIINWLDKNQtAEKEEFEHQQKELEKVCNPI |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P11766 | T127 | Sugiyama | ADH5 ADHX FDH | KTNLCQKIRVTQGKGLMPDGtSRFTCKGKTILHYMGTSTFS |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12268 | S508 | Sugiyama | IMPDH2 IMPD2 | LKFEKRtssAQVEGGVHsLHsyEKRLF______________ |
| P12268 | T252 | Sugiyama | IMPDH2 IMPD2 | DYPLASKDAKKQLLCGAAIGtHEDDKYRLDLLAQAGVDVVV |
| P12268 | Y509 | Sugiyama | IMPDH2 IMPD2 | KFEKRtssAQVEGGVHsLHsyEKRLF_______________ |
| P12814 | T340 | Sugiyama | ACTN1 | RRLHKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRM |
| P12814 | T343 | Sugiyama | ACTN1 | HKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRMVSD |
| P12814 | T490 | Sugiyama | ACTN1 | PsVNARCQKICDQWDNLGALtQKRREALERTEKLLETIDQL |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13489 | T176 | Sugiyama | RNH1 PRI RNH | AASCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKD |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T484 | Sugiyama | EEF2 EF2 | VPCGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPV |
| P13639 | T487 | Sugiyama | EEF2 EF2 | GNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPVVRV |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13667 | T380 | Sugiyama | PDIA4 ERP70 ERP72 | PEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGHR |
| P13667 | Y565 | Sugiyama | PDIA4 ERP70 ERP72 | DVLIEFYAPWCGHCKQLEPVyNsLAKKYKGQKGLVIAKMDA |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13674 | T147 | Sugiyama | P4HA1 P4HA | QVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDC |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P14314 | S445 | Sugiyama | PRKCSH G19P1 | YRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKy |
| P14314 | S451 | Sugiyama | PRKCSH G19P1 | KLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKyEQGtGC |
| P14314 | T115 | Sugiyama | PRKCSH G19P1 | GVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQQMAEVtR |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14314 | T479 | Sugiyama | PRKCSH G19P1 | KFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPSR |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T195 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | yVDDGLISLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAA |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T454 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SGRSAHQVARYRPRAPIIAVtRNPQtARQAHLYRGIFPVLC |
| P14618 | T459 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | HQVARYRPRAPIIAVtRNPQtARQAHLYRGIFPVLCKDPVQ |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14618 | T80 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | tLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAs |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P14625 | S680 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDMLRR |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P14625 | T450 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LNFVKGVVDsDDLPLNVsREtLQQHKLLKVIRKKLVRKTLD |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T299 | Sugiyama | EZR VIL2 | RILQLCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQLE |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15311 | T567 | EPSD|PSP | EZR VIL2 | RTHNDIIHNENMRQGRDKYKtLRQIRQGNTKQRIDEFEAL_ |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15531 | T103 | Sugiyama | NME1 NDPKA NM23 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P15880 | T202 | Sugiyama | RPS2 RPS4 | CKVTGRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDC |
| P15880 | T224 | Sugiyama | RPS2 RPS4 | IVsAPVPKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAI |
| P15880 | T230 | Sugiyama | RPS2 RPS4 | PKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysy |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P15924 | T61 | Sugiyama | DSP | YYSRRGVITDQNsDGyCQtGtMsRHQNQNTIQELLQNCSDC |
| P16070 | T76 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | FNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRIHPNSI |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16401 | T99 | Sugiyama | H1-5 H1F5 HIST1H1B | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | T97 | Sugiyama | H1-3 H1F3 HIST1H1D | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAASGEG |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | T96 | Sugiyama | H1-2 H1F2 HIST1H1C | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17655 | T306 | Sugiyama | CAPN2 CANPL2 | NPWGEVEWTGRWNDNCPSWNtIDPEERERLTRRHEDGEFWM |
| P17844 | S520 | Sugiyama | DDX5 G17P1 HELR HLR1 | GKRGGFNTFRDRENYDRGYssLLKRDFGAKTQNGVYSAANY |
| P17980 | T163 | Sugiyama | PSMC3 TBP1 | EKLKPGDLVGVNKDSyLILEtLPtEyDsRVKAMEVDERPtE |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18621 | T12 | Sugiyama | RPL17 | _________MVRysLDPENPtKsCKSRGSNLRVHFKNtRET |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P20290 | T28 | Sugiyama | BTF3 NACB OK/SW-cl.8 | AQADSRGRGRARGGCPGGEAtLsQPPPRGGTRGQEPQMKET |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22314 | T600 | Sugiyama | UBA1 A1S9T UBE1 | ARMYMDRRCVYYRKPLLESGtLGtKGNVQVVIPFLTESySS |
| P22392 | T103 | Sugiyama | NME2 NM23B | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P22626 | Y234 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyNGyGGGPGGG |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23284 | T108 | Sugiyama | PPIB CYPB | YKNSKFHRVIKDFMIQGGDFtRGDGtGGKsIyGERFPDENF |
| P23284 | T113 | Sugiyama | PPIB CYPB | FHRVIKDFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHy |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23381 | T364 | Sugiyama | WARS1 IFI53 WARS WRS | QGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFsGGRDtI |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | T88 | Sugiyama | CFL1 CFL | yAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPES |
| P23528 | T91 | Sugiyama | CFL1 CFL | FVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P24752 | T220 | Sugiyama | ACAT1 ACAT MAT | TAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVtV |
| P24752 | T285 | Sugiyama | ACAT1 ACAT MAT | PKLKTVFQKENGTVTAANAStLNDGAAALVLMTADAAKRLN |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P25963 | S32 | EPSD | NFKBIA IKBA MAD3 NFKBI | AMEGPRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEI |
| P25963 | S36 | EPSD | NFKBIA IKBA MAD3 NFKBI | PRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEIRLEP |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T299 | Sugiyama | MSN | RILALCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQME |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26038 | T558 | EPSD|PSP | MSN | KTANDMIHAENMRLGRDKYKtLRQIRQGNTKQRIDEFEsM_ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | S97 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | sLEELRVAGIHKKVARTIGIsVDPRRRNKstEsLQANVQRL |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26373 | T24 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | SRNGMVLKPHFHKDWQRRVAtWFNQPARKIRRRKARQAKAR |
| P26639 | T250 | Sugiyama | TARS1 TARS | FKYNKFKCRILNEKVNtPtttVyRCGPLIDLCRGPHVRHTG |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P26641 | T409 | Sugiyama | EEF1G EF1G PRO1608 | DWQVDyESyTWRKLDPGsEEtQtLVREyFSWEGAFQHVGKA |
| P26641 | T411 | Sugiyama | EEF1G EF1G PRO1608 | QVDyESyTWRKLDPGsEEtQtLVREyFSWEGAFQHVGKAFN |
| P27348 | T24 | Sugiyama | YWHAQ | TELIQKAKLAEQAERyDDMAtCMKAVtEQGAELsNEERNLL |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P28066 | S159 | Sugiyama | PSMA5 | VALLFGGVDEKGPQLFHMDPsGtFVQCDARAIGsAsEGAQs |
| P29401 | T342 | Sugiyama | TKT | GQALAKLGHAsDRIIALDGDtKNstFsEIFKKEHPDRFIEC |
| P29401 | T346 | Sugiyama | TKT | AKLGHAsDRIIALDGDtKNstFsEIFKKEHPDRFIECYIAE |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30043 | T190 | Sugiyama | BLVRB FLR SCAN | RGPSRVISKHDLGHFMLRCLttDEyDGHstyPsHQyQ____ |
| P30043 | T191 | Sugiyama | BLVRB FLR SCAN | GPSRVISKHDLGHFMLRCLttDEyDGHstyPsHQyQ_____ |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30050 | T18 | Sugiyama | RPL12 | ___MPPKFDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLs |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P30086 | S109 | Sugiyama | PEBP1 PBP PEBP | VVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyEQDR |
| P30086 | S99 | Sugiyama | PEBP1 PBP PEBP | PKYREWHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHR |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30740 | S72 | Sugiyama | SERPINB1 ELANH2 MNEI PI2 | AQLSKTFHFNTVEEVHSRFQsLNADINKRGASYILKLANRL |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31327 | T900 | Sugiyama | CPS1 | KMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKC |
| P31327 | T903 | Sugiyama | CPS1 | DILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKCLGL |
| P31942 | S298 | Sugiyama | HNRNPH3 HNRPH3 | GGsGMGGYGRDGMDNQGGyGsVGRMGMGNNysGGyGtPDGL |
| P31943 | S281 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | GRDLNyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAt |
| P31943 | S285 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | NyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDI |
| P31943 | T282 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | RDLNyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtE |
| P31943 | T286 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDIy |
| P31947 | T207 | Sugiyama | SFN HME1 | PEEAISLAKTtFDEAMADLHtLsEDsyKDstLIMQLLRDNL |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P32969 | T186 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | TVKNKDIRKFLDGIyVsEKGtVQQADE______________ |
| P33176 | T809 | Sugiyama | KIF5B KNS KNS1 | VAKELQTLHNLRKLFVQDLAtRVKKSAEIDsDDTGGsAAQK |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P35080 | T85 | Sugiyama | PFN2 | tLGAKKCSVIRDSLyVDGDCtMDIRTKsQGGEPTyNVAVGR |
| P35241 | T299 | Sugiyama | RDX | RILALCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQLE |
| P35241 | T564 | EPSD|PSP | RDX | KTQNDVLHAENVKAGRDKYKtLRQIRQGNtKQRIDEFEAM_ |
| P35268 | T62 | Sugiyama | RPL22 | FLQERIKVNGKAGNLGGGVVtIERsKSKITVTSEVPFSKRY |
| P35579 | T1208 | Sugiyama | MYH9 | QEMRQKHsQAVEELAEQLEQtKRVKANLEKAKQtLENERGE |
| P35606 | S160 | Sugiyama | COPB2 | GHTHYVMQIVINPKDNNQFAsAsLDRtIKVWQLGsssPNFT |
| P35606 | S162 | Sugiyama | COPB2 | THYVMQIVINPKDNNQFAsAsLDRtIKVWQLGsssPNFTLE |
| P35606 | T166 | Sugiyama | COPB2 | MQIVINPKDNNQFAsAsLDRtIKVWQLGsssPNFTLEGHEK |
| P35609 | T347 | Sugiyama | ACTN2 | RRKHKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKM |
| P35609 | T350 | Sugiyama | ACTN2 | HKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKMVSD |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36871 | S483 | Sugiyama | PGM1 | DKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTDGSRIVFR |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37802 | S145 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | VQRTLMNLGGLAVARDDGLFsGDPNWFPKKSKENPRNFsDN |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38117 | T172 | Sugiyama | ETFB FP585 | QVTLEGDKLKVEREIDGGLEtLRLKLPAVVTADLRLNEPRy |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | T60 | Sugiyama | RPS19 | AKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIYG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40429 | T153 | Sugiyama | RPL13A | RKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQ |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P40429 | T64 | Sugiyama | RPL13A | sGNFyRNKLKYLAFLRKRMNtNPSRGPyHFRAPsRIFWRTV |
| P40925 | T135 | Sugiyama | MDH1 MDHA | ALDKYAKKSVKVIVVGNPANtNCLtAsKSAPSIPKENFsCL |
| P40925 | T139 | Sugiyama | MDH1 MDHA | YAKKSVKVIVVGNPANtNCLtAsKSAPSIPKENFsCLtRLD |
| P40925 | T226 | Sugiyama | MDH1 MDHA | EVGVyEALKDDsWLKGEFVttVQQRGAAVIKARKLssAMSA |
| P40939 | T393 | Sugiyama | HADHA HADH | GAGIAQVSVDKGLKTILKDAtLtALDRGQQQVFKGLNDKVK |
| P41091 | S410 | Sugiyama | EIF2S3 EIF2G | KKAAKVQKLSKNEVLMVNIGsLstGGRVSAVKADLGKIVLt |
| P41091 | S412 | Sugiyama | EIF2S3 EIF2G | AAKVQKLSKNEVLMVNIGsLstGGRVSAVKADLGKIVLtNP |
| P41091 | T21 | Sugiyama | EIF2S3 EIF2G | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| P41091 | T41 | Sugiyama | EIF2S3 EIF2G | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| P41091 | T413 | Sugiyama | EIF2S3 EIF2G | AKVQKLSKNEVLMVNIGsLstGGRVSAVKADLGKIVLtNPV |
| P41091 | T46 | Sugiyama | EIF2S3 EIF2G | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHt |
| P42166 | T137 | Sugiyama | TMPO LAP2 | NEDLLDQLVKyGVNPGPIVGttRKLYEKKLLKLREQGtEsR |
| P42167 | T137 | Sugiyama | TMPO LAP2 | NEDLLDQLVKyGVNPGPIVGtTRKLYEKKLLKLREQGTESR |
| P42336 | T1061 | SIGNOR | PIK3CA | KQMNDAHHGGWTTKMDWIFHtIKQHALN_____________ |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42677 | T74 | Sugiyama | RPS27 MPS1 | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| P42858 | S13 | PSP | HTT HD IT15 | ________MAtLEKLMKAFEsLKsFQQQQQQQQQQQQQQQQ |
| P42858 | T3 | PSP | HTT HD IT15 | __________________MAtLEKLMKAFEsLKsFQQQQQQ |
| P43034 | T247 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | VKTFTGHREWVRMVRPNQDGtLIASCSNDQTVRVWVVATKE |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46778 | T124 | Sugiyama | RPL21 | sFLKRVKENDQKKKEAKEKGtWVQLKRQPAPPREAHFVRTN |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46779 | S76 | Sugiyama | RPL28 | DGKGVVVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHM |
| P46779 | T75 | Sugiyama | RPL28 | ADGKGVVVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRH |
| P46779 | T80 | Sugiyama | RPL28 | VVVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKN |
| P46779 | T81 | Sugiyama | RPL28 | VVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKNK |
| P46782 | S75 | Sugiyama | RPS5 | RYAAKRFRKAQCPIVERLtNsMMMHGRNNGKKLMTVRIVKH |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P47756 | T186 | Sugiyama | CAPZB | HYKLTSTVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDC |
| P48426 | S115 | Sugiyama | PIP4K2A PI5P4KA PIP5K2 PIP5K2A | PMVFRNLRERFGIDDQDFQNsLTRSAPLPNDSQARSGARFH |
| P48643 | T47 | Sugiyama | CCT5 CCTE KIAA0098 | RLMGLEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGD |
| P48643 | T50 | Sugiyama | CCT5 CCTE KIAA0098 | GLEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtV |
| P48739 | S165 | Sugiyama | PITPNB | DRSQVEPADyKADEDPALFQsVKtKRGPLGPNWKKELANsP |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49327 | T217 | Sugiyama | FASN FAS | SVQFLRLGMLsPEGtCKAFDtAGNGYCRSEGVVAVLLTKKS |
| P49368 | T373 | Sugiyama | CCT3 CCTG TRIC5 | KKIGDEYFTFITDCKDPKACtILLRGAsKEILSEVERNLQD |
| P49368 | T459 | Sugiyama | CCT3 CCTG TRIC5 | AVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWG |
| P49368 | T464 | Sugiyama | CCT3 CCTG TRIC5 | LEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWGVNGEt |
| P49411 | T433 | Sugiyama | TUFM | LRQPMILEKGQRFTLRDGNRtIGTGLVTNTLAMTEEEKNIK |
| P49589 | S34 | Sugiyama | CARS1 CARS | VQPQWsPPAGtQPCRLHLyNsLtRNKEVFIPQDGKKVTWYC |
| P50395 | T205 | Sugiyama | GDI2 RABGDIB | TGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsPYL |
| P50416 | T370 | Sugiyama | CPT1A CPT1 | DGRLLKPREMEQQMQRILDNtsEPQPGEARLAALTAGDRVP |
| P50897 | T265 | Sugiyama | PPT1 CLN1 PPT | GFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLAT |
| P50914 | T43 | Sugiyama | RPL14 | KLVAIVDVIDQNRALVDGPCtQVRRQAMPFKCMQLTDFILK |
| P50990 | T398 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | RGstDNLMDDIERAVDDGVNtFKVLTRDKRLVPGGGAtEIE |
| P50991 | T69 | Sugiyama | CCT4 CCTD SRB | RtsLGPKGMDKMIQDGKGDVtItNDGAtILKQMQVLHPAAR |
| P50991 | T71 | Sugiyama | CCT4 CCTD SRB | sLGPKGMDKMIQDGKGDVtItNDGAtILKQMQVLHPAARML |
| P50991 | T76 | Sugiyama | CCT4 CCTD SRB | GMDKMIQDGKGDVtItNDGAtILKQMQVLHPAARMLVELSK |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51153 | S164 | Sugiyama | RAB13 GIG4 | GIRFFETSAKSsMNVDEAFSsLARDILLKSGGRRsGNGNKP |
| P51532 | T1396 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EVDYsDsLTEKQWLKAIEEGtLEEIEEEVRQKKSSRKRKRD |
| P51858 | T184 | Sugiyama | HDGF HMG1L2 | DsPKRPKEAENPEGEEKEAAtLEVERPLPMEVEKNstPsEP |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P52907 | T217 | Sugiyama | CAPZA1 | HYYEDGNVQLVSHKDVQDsLtVsNEAQtAKEFIKIIENAEN |
| P53621 | T390 | Sugiyama | COPA | YNPAENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPEG |
| P53621 | T395 | Sugiyama | COPA | NAVLLCTRAsNLENstyDLytIPKDADsQNPDAPEGKRSSG |
| P53621 | T821 | Sugiyama | COPA | IMPLDTNWPLLTVSKGFFEGtIAsKGKGGALAADIDIDTVG |
| P53634 | T431 | Sugiyama | CTSC CPPI | GYGTDSASGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIE |
| P53999 | S104 | Sugiyama | SUB1 PC4 RPO2TC1 | DIREYWMDPEGEMKPGRKGIsLNPEQWsQLKEQIsDIDDAV |
| P53999 | S111 | Sugiyama | SUB1 PC4 RPO2TC1 | DPEGEMKPGRKGIsLNPEQWsQLKEQIsDIDDAVRKL____ |
| P54136 | T383 | Sugiyama | RARS1 RARS | IVFVPGCSIPLTIVKsDGGytyDtSDLAAIKQRLFEEKADM |
| P54136 | T386 | Sugiyama | RARS1 RARS | VPGCSIPLTIVKsDGGytyDtSDLAAIKQRLFEEKADMIIY |
| P54577 | T130 | Sugiyama | YARS1 YARS | VPLEKLKFIKGTDYQLSKEytLDVyRLSSVVTQHDSKKAGA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55060 | T339 | Sugiyama | CSE1L CAS XPO2 | QFLASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADE |
| P55209 | S69 | Sugiyama | NAP1L1 NRP | LAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQVKCA |
| P55209 | T64 | Sugiyama | NAP1L1 NRP | QNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNL |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P56192 | S127 | Sugiyama | MARS1 MARS | GKKGEDVLGSVRRALTHIDHsLSRQNCPFLAGETESLADIV |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T173 | Sugiyama | TPI1 TPI | DNVKDWSKVVLAyEPVWAIGtGKtATPQQAQEVHEKLRGWL |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T203 | Sugiyama | ACTB | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60842 | T80 | Sugiyama | EIF4A1 DDX2A EIF4A | QRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDLKA |
| P61160 | T237 | EPSD | ACTR2 ARP2 | KEKLCYVGYNIEQEQKLALEttVLVESYTLPDGRIIKVGGE |
| P61160 | T238 | EPSD | ACTR2 ARP2 | EKLCYVGYNIEQEQKLALEttVLVESYTLPDGRIIKVGGER |
| P61160 | Y202 | EPSD | ACTR2 ARP2 | LDIAGRDITRYLIKLLLLRGyAFNHSADFETVRMIKEKLCY |
| P61163 | T248 | Sugiyama | ACTR1A CTRN1 | PQKDETLETEKAQyyLPDGstIEIGPSRFRAPELLFRPDLI |
| P61204 | S147 | Sugiyama | ARF3 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61254 | S23 | Sugiyama | RPL26 | FNPFVtsDRsKNRKRHFNAPsHIRRKIMssPLSKELRQKYN |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61513 | S21 | Sugiyama | RPL37A | MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAKYTCSF |
| P61513 | S75 | Sugiyama | RPL37A | WHCGsCMKTVAGGAWTyNtTsAVtVKSAIRRLKELKDQ___ |
| P61513 | T16 | Sugiyama | RPL37A | _____MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAK |
| P61513 | T73 | Sugiyama | RPL37A | GIWHCGsCMKTVAGGAWTyNtTsAVtVKSAIRRLKELKDQ_ |
| P61513 | T78 | Sugiyama | RPL37A | GsCMKTVAGGAWTyNtTsAVtVKSAIRRLKELKDQ______ |
| P61513 | Y14 | Sugiyama | RPL37A | _______MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQH |
| P61513 | Y71 | Sugiyama | RPL37A | AVGIWHCGsCMKTVAGGAWTyNtTsAVtVKSAIRRLKELKD |
| P61769 | T106 | Sugiyama | B2M CDABP0092 HDCMA22P | YYTEFTPTEKDEYACRVNHVtLsQPKIVKWDRDM_______ |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | T390 | Sugiyama | HNRNPK HNRPK | DYSYAGGRGsyGDLGGPIIttQVtIPKDLAGsIIGKGGQRI |
| P61978 | T393 | Sugiyama | HNRNPK HNRPK | YAGGRGsyGDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQI |
| P62191 | T56 | Sugiyama | PSMC1 | KKKKTKGPDAASKLPLVtPHtQCRLKLLKLERIKDYLLMEE |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62241 | S66 | Sugiyama | RPS8 OK/SW-cl.83 | VRVRGGNKKYRALRLDVGNFsWGSECCTRKTRIIDVVyNAS |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62269 | T69 | Sugiyama | RPS18 D6S218E | DIDLTKRAGELtEDEVERVItIMQNPRQYKIPDWFLNRQKD |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62424 | T142 | Sugiyama | RPL7A SURF-3 SURF3 | AAGKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVD |
| P62424 | T144 | Sugiyama | RPL7A SURF-3 SURF3 | GKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPI |
| P62424 | T145 | Sugiyama | RPL7A SURF-3 SURF3 | KGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPIE |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62424 | T93 | Sugiyama | RPL7A SURF-3 SURF3 | RLKVPPAINQFtQALDRQTAtQLLKLAHKYRPEtKQEKKQR |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62753 | T127 | Sugiyama | RPS6 OK/SW-cl.2 | SVLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNL |
| P62753 | T128 | Sugiyama | RPS6 OK/SW-cl.2 | VLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNLs |
| P62826 | S150 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARKLIG |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T24 | Sugiyama | RAN ARA24 OK/SW-cl.81 | QGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVATLG |
| P62826 | T25 | Sugiyama | RAN ARA24 OK/SW-cl.81 | GEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGV |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62847 | S78 | Sugiyama | RPS24 | FGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGLYE |
| P62847 | T69 | Sugiyama | RPS24 | KTTPDVIFVFGFRTHFGGGKttGFGMIyDsLDyAKKNEPKH |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62899 | T107 | Sugiyama | RPL31 | RLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN__ |
| P62899 | T112 | Sugiyama | RPL31 | RNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN_______ |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | T147 | Sugiyama | RPS27A UBA80 UBCEP1 | GAGVFMAsHFDRHyCGKCCLtyCFNKPEDK___________ |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63151 | S409 | Sugiyama | PPP2R2A | RTVLKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKEN |
| P63151 | S412 | Sugiyama | PPP2R2A | LKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKENIIA |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63241 | S100 | Sugiyama | EIF5A | DVPNIKRNDFQLIGIQDGyLsLLQDSGEVREDLRLPEGDLG |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T203 | Sugiyama | ACTG1 ACTG | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T89 | Sugiyama | YBX1 NSEP1 YB1 | RNGyGFINRNDtKEDVFVHQtAIKKNNPRKyLRsVGDGEtV |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68363 | T41 | Sugiyama | TUBA1B | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78406 | T77 | Sugiyama | RAE1 MRNP41 | LIAGSWANDVRCWEVQDsGQtIPKAQQMHTGPVLDVCWSDD |
| P78417 | S23 | Sugiyama | GSTO1 GSTTLP28 | GESARsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84077 | S147 | Sugiyama | ARF1 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P99999 | T50 | Sugiyama | CYCS CYC | GPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEYLE |
| Q00341 | T729 | Sugiyama | HDLBP HBP VGL | VEKAKKQLLHLAEEKQTKSFtVDIRAKPEYHKFLIGKGGGK |
| Q00653 | S866 | EPSD | NFKB2 LYT10 | LLRGPETRDKLPstAEVKEDsAyGsQsVEQEAEKLGPPPEP |
| Q00653 | S870 | EPSD | NFKB2 LYT10 | PETRDKLPstAEVKEDsAyGsQsVEQEAEKLGPPPEPPGGL |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q00839 | T549 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GtNtIMDKMMVAGFKKQMADtGKLNtLLQRAPQCLGKFIEI |
| Q00839 | T554 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | MDKMMVAGFKKQMADtGKLNtLLQRAPQCLGKFIEIAARKK |
| Q01082 | T1841 | Sugiyama | SPTBN1 SPTB2 | IQDKHKKLPEELGRDQNTVEtLQRMHTTFEHDIQALGTQVR |
| Q01105 | S165 | Sugiyama | SET | PyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQ |
| Q01518 | T165 | Sugiyama | CAP1 CAP | AMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVKA |
| Q01518 | Y164 | Sugiyama | CAP1 CAP | VAMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVK |
| Q01650 | T45 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | KMLAAKsADGsAPAGEGEGVtLQRNITLLNGVAIIVGTIIG |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q02539 | T99 | Sugiyama | H1-1 H1F1 HIST1H1A | NNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKASSVET |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02543 | T101 | Sugiyama | RPL18A | WLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARA |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02543 | T24 | Sugiyama | RPL18A | SGTLREYKVVGRCLPTPKCHtPPLYRMRIFAPNHVVAKSRF |
| Q02543 | Y97 | Sugiyama | RPL18A | NFGIWLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARH |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q02878 | T91 | Sugiyama | RPL6 TXREB1 | RKYSAAKSKVEKKKKEKVLAtVtKPVGGDKNGGTRVVKLRK |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T156 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | KGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEVCPAG |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T39 | Sugiyama | RPL18 | KSQDIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRP |
| Q07020 | T42 | Sugiyama | RPL18 | DIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRPPLs |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q08043 | T354 | Sugiyama | ACTN3 | RRLHKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKL |
| Q08043 | T357 | Sugiyama | ACTN3 | HKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKLVSD |
| Q08J23 | S322 | Sugiyama | NSUN2 SAKI TRM4 | IATRGAEQLAEGGRMVYSTCsLNPIEDEAVIASLLEKSEGA |
| Q12792 | T348 | Sugiyama | TWF1 PTK9 | GPAGKRGIRRLIRGPAEtEAttD__________________ |
| Q12906 | T188 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | TIHLTSPVVREEMEKVLAGEtLsVNDPPDVLDRQKCLAALA |
| Q12965 | S943 | Sugiyama | MYO1E MYO1C | GLPKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPPGyHQ |
| Q12965 | T945 | Sugiyama | MYO1E MYO1C | PKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPPGyHQNG |
| Q13011 | T208 | Sugiyama | ECH1 | AQDAFFQVKEVDVGLAADVGtLQRLPKVIGNQSLVNELAFT |
| Q13085 | T833 | Sugiyama | ACACA ACAC ACC1 ACCA | CVLAKMQLDNPSKVQQAELHtGsLPRIQSTALRGEKLHRVF |
| Q13347 | T218 | Sugiyama | EIF3I EIF3S2 TRIP1 | RDMtMFVtASKDNTAKLFDsttLEHQKTFRTERPVNSAALs |
| Q13347 | T219 | Sugiyama | EIF3I EIF3S2 TRIP1 | DMtMFVtASKDNTAKLFDsttLEHQKTFRTERPVNSAALsP |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13561 | S391 | Sugiyama | DCTN2 DCTN50 | LTQVQTTMRENLATVEGNFAsIDERMKKLGK__________ |
| Q13561 | T315 | Sugiyama | DCTN2 DCTN50 | KHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRLVT |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14028 | S958 | Sugiyama | CNGB1 CNCG2 CNCG3L CNCG4 RCNC2 | VQLPDKMRLDLAIDVNyNIVsKVALFQGCDRQMIFDMLKRL |
| Q14028 | Y954 | Sugiyama | CNGB1 CNCG2 CNCG3L CNCG4 RCNC2 | SELMVQLPDKMRLDLAIDVNyNIVsKVALFQGCDRQMIFDM |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14152 | T734 | Sugiyama | EIF3A EIF3S10 KIAA0139 | YEEQRIKDMDLWEQQEEERIttMQLEREKALEHKNRMSRML |
| Q14204 | T2267 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | VEGVAHIIDPKAISKDHLyGtLDPNTREWTDGLFTHVLRKI |
| Q14204 | T4218 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | PLGWSKKYEFGESDLRSACDtVDtWLDDTAKGRQNISPDKI |
| Q14204 | T4221 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | WSKKYEFGESDLRSACDtVDtWLDDTAKGRQNISPDKIPWS |
| Q14240 | T81 | Sugiyama | EIF4A2 DDX2B EIF4F | QRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEFKE |
| Q14247 | T68 | Sugiyama | CTTN EMS1 | GHQEHINIHKLRENVFQEHQtLKEKELETGPKASHGyGGKF |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S169 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | TVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILH |
| Q14568 | T109 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LTIVDTGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q14683 | T1005 | Sugiyama | SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1 | DLCEDLKDAQAEEEIKQEMNtLQQKLNEQQsVLQRIAAPNM |
| Q14684 | S422 | Sugiyama | RRP1B KIAA0179 | KKKKKHHLQPENPGPGGAAPsLEQNRGREPEASGLKALKAR |
| Q14694 | S265 | Sugiyama | USP10 KIAA0190 | GPGADFGQsCFPAEAGRDtLsRTAGAQPCVGTDTTENLGVA |
| Q14694 | T263 | Sugiyama | USP10 KIAA0190 | EGGPGADFGQsCFPAEAGRDtLsRTAGAQPCVGTDTTENLG |
| Q14697 | T40 | Sugiyama | GANAB G2AN KIAA0088 | LAFLGVCLGITLAVDRSNFKtCEEssFCKRQRsIRPGLsPy |
| Q15021 | S1310 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | RACHTRGLDGIKELEIGQAGsQRAPsAKKPSTGSRyQPLAs |
| Q15084 | T239 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AVDAtVNQVLAsRYGIRGFPtIKIFQKGEsPVDyDGGRTRs |
| Q15459 | S508 | Sugiyama | SF3A1 SAP114 | IGEEEIQKPEEKVTWDGHsGsMARTQQAAQANITLQEQIEA |
| Q15648 | S1493 | Sugiyama | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | EKsyQNsPssDDGIRPLPEYstEKHKKHKKEKKKVKDKDRD |
| Q15797 | T322 | GPS6|SIGNOR|EPSD|PSP | SMAD1 BSP1 MADH1 MADR1 | PSNNKNRFCLGLLsNVNRNstIENTRRHIGKGVHLYYVGGE |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q16584 | T738 | SIGNOR|PSP | MAP3K11 MLK3 PTK1 SPRK | IPVGQRsAKsPRREEEPRGGtVsPPPGTSRsAPGtPGTPRs |
| Q16658 | S120 | Sugiyama | FSCN1 FAN1 HSN SNL | RWSLQSEAHRRYFGGtEDRLsCFAQtVsPAEKWSVHIAMHP |
| Q16658 | T115 | Sugiyama | FSCN1 FAN1 HSN SNL | AHDDGRWSLQSEAHRRYFGGtEDRLsCFAQtVsPAEKWSVH |
| Q16658 | T125 | Sugiyama | FSCN1 FAN1 HSN SNL | SEAHRRYFGGtEDRLsCFAQtVsPAEKWSVHIAMHPQVNIY |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16658 | T79 | Sugiyama | FSCN1 FAN1 HSN SNL | AVCLRSHLGRyLAADKDGNVtCEREVPGPDCRFLIVAHDDG |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16775 | T291 | Sugiyama | HAGH GLO2 HAGH1 | PFMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD___ |
| Q27J81 | T1206 | Sugiyama | INF2 C14orf151 C14orf173 | DtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKKRP |
| Q2VIR3 | S410 | Sugiyama | EIF2S3B | KKAAKVQKLSKNEVLMVNIGsLstGGRVSAVKADLGKIVLt |
| Q2VIR3 | S412 | Sugiyama | EIF2S3B | AAKVQKLSKNEVLMVNIGsLstGGRVSAVKADLGKIVLtNP |
| Q2VIR3 | T21 | Sugiyama | EIF2S3B | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| Q2VIR3 | T41 | Sugiyama | EIF2S3B | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| Q2VIR3 | T413 | Sugiyama | EIF2S3B | AKVQKLSKNEVLMVNIGsLstGGRVSAVKADLGKIVLtNPV |
| Q2VIR3 | T46 | Sugiyama | EIF2S3B | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHT |
| Q32P51 | S22 | Sugiyama | HNRNPA1L2 HNRNPA1L | SKSASPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTD |
| Q32P51 | T25 | Sugiyama | HNRNPA1L2 HNRNPA1L | ASPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTDCVV |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q3ZCM7 | T72 | Sugiyama | TUBB8 | NEASGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIF |
| Q4G0X9 | S553 | Sugiyama | CCDC40 KIAA1640 | EIEAYKKSIMKEEEKNEKLAsILNRTETEATLLQKLTTQCL |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | S67 | Sugiyama | HSP90AB3P HSP90BC | ASDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERTLALV |
| Q58FF7 | T489 | Sugiyama | HSP90AB3P HSP90BC | YGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIME |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S67 | Sugiyama | HSP90AB2P HSP90BB | ASDALDKIRyEsLtDPsKLDsGKELKIDIIPNTQEHTLTLV |
| Q58FF8 | T104 | Sugiyama | HSP90AB2P HSP90BB | LTLVDTGIGMTKADLINNLGtIAKFQDQTEYLEEMQVKEVV |
| Q58FG1 | T28 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | SKLDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| Q58FG1 | T30 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | LDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLGTI |
| Q5T5C0 | T703 | Sugiyama | STXBP5 LLGL3 | RSPRKsRQPsGAGLCDIsEGtVVPEDRCKSPTSGSSsPHNs |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q66LE6 | S415 | Sugiyama | PPP2R2D KIAA1541 | RASLKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDN |
| Q66LE6 | S418 | Sugiyama | PPP2R2D KIAA1541 | LKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDNVIA |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6PEY2 | T41 | Sugiyama | TUBA3E | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6XQN6 | S500 | Sugiyama | NAPRT FHIP NAPRT1 | QGQLCEPLPSLAESRALAQLsLSRLSPEHRRLRsPAQYQVV |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | T41 | Sugiyama | TUBA1A TUBA3 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q71UM5 | T74 | Sugiyama | RPS27L | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| Q86UE4 | T331 | Sugiyama | MTDH AEG1 LYRIC | sAGKRKtEPSAWsQDtGDANtNGKDWGRsWsDRsIFsGIGs |
| Q86UE4 | T477 | Sugiyama | MTDH AEG1 LYRIC | stAQDtEELEKEIREDLPVNtsKTRPKQEKAFSLKtIstsD |
| Q8NBJ7 | T260 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | SPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPD |
| Q8NBJ7 | T42 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | LGNGQATSMVQLQGGRFLMGtNsPDSRDGDGPVREATVKPF |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WU90 | S351 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLsEAs |
| Q8WU90 | T348 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | sVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLs |
| Q92598 | T63 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | SKNRTIGVAAKNQQITHANNtVsNFKRFHGRAFNDPFIQKE |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q96AY3 | T160 | Sugiyama | FKBP10 FKBP65 PSEC0056 | LYFDVVLLDVWNKEDTVQVStLLRPPHCPRMVQDGDFVRYH |
| Q96AY3 | T200 | Sugiyama | FKBP10 FKBP65 PSEC0056 | HYNGTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLG |
| Q96AY3 | T203 | Sugiyama | FKBP10 FKBP65 PSEC0056 | GTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGMCP |
| Q96G46 | T99 | Sugiyama | DUS3L | DGQtADGQtEEAAEPGEQLQtQKRARGQNKGRPHVKPTNYD |
| Q96HC4 | T80 | Sugiyama | PDLIM5 ENH L9 | GMTHLEAQNKIKGCTGsLNMtLQRAsAAPKPEPVPVQKGEP |
| Q96IZ0 | T261 | Sugiyama | PAWR PAR4 | YsRTDRSGFPRYNRDANVsGtLVSSstLEKKIEDLEKEVVR |
| Q96QK1 | T773 | Sugiyama | VPS35 MEM3 TCCCTA00141 | DLPNLEssEEtEQINKHFHNtLEHLRLRREsPEsEGPIyEG |
| Q99426 | T108 | Sugiyama | TBCB CG22 CKAP1 | IDHsGARLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKRs |
| Q99426 | T120 | Sugiyama | TBCB CG22 CKAP1 | DVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyNEEERAQ |
| Q99426 | Y107 | Sugiyama | TBCB CG22 CKAP1 | VIDHsGARLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKR |
| Q99436 | T270 | Sugiyama | PSMB7 Z | GTTAVLTEKITPLEIEVLEEtVQtMDts_____________ |
| Q99436 | T273 | Sugiyama | PSMB7 Z | AVLTEKITPLEIEVLEEtVQtMDts________________ |
| Q99436 | T276 | Sugiyama | PSMB7 Z | TEKITPLEIEVLEEtVQtMDts___________________ |
| Q99497 | S57 | Sugiyama | PARK7 | GLAGKDPVQCsRDVVICPDAsLEDAKKEGPyDVVVLPGGNL |
| Q99547 | T120 | Sugiyama | MPHOSPH6 MPP6 | VEDETVELDVsDEEMARRyEtLVGtIGKKFARKRDHANYEE |
| Q99547 | T124 | Sugiyama | MPHOSPH6 MPP6 | TVELDVsDEEMARRyEtLVGtIGKKFARKRDHANYEEDENG |
| Q99547 | Y118 | Sugiyama | MPHOSPH6 MPP6 | EEVEDETVELDVsDEEMARRyEtLVGtIGKKFARKRDHANY |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99729 | S242 | Sugiyama | HNRNPAB ABBP1 HNRPAB | SKCEIKVAQPKEVyQQQQyGsGGRGNRNRGNRGSGGGGGGG |
| Q99832 | S96 | Sugiyama | CCT7 CCTH NIP7-1 | AKTLVDIAKSQDAEVGDGTTsVtLLAAEFLKQVKPYVEEGL |
| Q99832 | T458 | Sugiyama | CCT7 CCTH NIP7-1 | yAKALEIIPRQLCDNAGFDAtNILNKLRARHAQGGTWYGVD |
| Q99832 | T98 | Sugiyama | CCT7 CCTH NIP7-1 | TLVDIAKSQDAEVGDGTTsVtLLAAEFLKQVKPYVEEGLHP |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BQE3 | T41 | Sugiyama | TUBA1C TUBA6 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQG0 | S1207 | Sugiyama | MYBBP1A P160 | EDGtPAEDGtPAATGGsQPPsMGRKKRNRTKAKVPAQANGt |
| Q9BS26 | T155 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | yIRQQKSDPIQEIRDLAEIttLDRSKRNIIGYFEQKDSDNy |
| Q9BTC0 | T355 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | QQEAKWRPGDADGTDCTsIGtIEQKSSEDQGIKGRIEKAAN |
| Q9BUF5 | T72 | Sugiyama | TUBB6 | NESssQKYVPRAALVDLEPGtMDsVRSGPFGQLFRPDNFIF |
| Q9BUJ2 | S512 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | IQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIVIC |
| Q9BV20 | T351 | Sugiyama | MRI1 MRDI UNQ6390/PRO21135 | DLITGGIITELGVFAPEELRtALTTTISSRDGtLDGPQM__ |
| Q9BV20 | T363 | Sugiyama | MRI1 MRDI UNQ6390/PRO21135 | VFAPEELRtALTTTISSRDGtLDGPQM______________ |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BXS5 | T422 | Sugiyama | AP1M1 CLTNM | GYQALPWVRYITQNGDyQLRtQ___________________ |
| Q9BY43 | T82 | Sugiyama | CHMP4A C14orf123 SHAX2 CDA04 HSPC134 | ALQALRRKKRFEQQLAQTDGtLStLEFQREAIENATtNAEV |
| Q9BY43 | T85 | Sugiyama | CHMP4A C14orf123 SHAX2 CDA04 HSPC134 | ALRRKKRFEQQLAQTDGtLStLEFQREAIENATtNAEVLRT |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BZI7 | T153 | Sugiyama | UPF3B RENT3B UPF3X | FAPFQKAAKKKTKKRDTKVGtIDDDPEyRKFLEsyAtDNEK |
| Q9H173 | T125 | Sugiyama | SIL1 UNQ545/PRO836 | QYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEME |
| Q9H2U1 | T179 | Sugiyama | DHX36 DDX36 KIAA1488 MLEL1 RHAU | NRsyIDRDsEyLLQENEPDGtLDQKLLEDLQKKKNDLRYIE |
| Q9H3K6 | T27 | Sugiyama | BOLA2 BOLA2A My016; BOLA2B | YLREKLQRDLEAEHVEVEDttLNRCsCsFRVLVVSAKFEGK |
| Q9H788 | S124 | Sugiyama | SH2D4A PPP1R38 SH2A | LKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKD |
| Q9NPA8 | S100 | Sugiyama | ENY2 DC6 | PDSVKKELLQRIRTFLAQHAsL___________________ |
| Q9NR45 | S253 | Sugiyama | NANS SAS | KVLERHITLDKTWKGsDHsAsLEPGELAELVRSVRLVERAL |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9NTZ6 | T407 | Sugiyama | RBM12 KIAA0765 HRIHFB2091 | GHITFKQNMGPSGQTHPPPQtLPRSKsPsGQKRsRsRsPHE |
| Q9NY33 | T198 | Sugiyama | DPP3 | MEDAKLAQDFLDsQNLsAyNtRLFKEVDGEGKPYYEVRLAs |
| Q9NZZ3 | T23 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | RLFGKAKPKAPPPsLtDCIGtVDsRAEsIDKKISRLDAELV |
| Q9P0J1 | T494 | Sugiyama | PDP1 PDP PPM2C | EDQNAATHLIRHAVGNNEFGtVDHERLSKMLSLPEELARMY |
| Q9P2E9 | T684 | Sugiyama | RRBP1 KIAA1398 | EGEAQRLIEILSEKAGIIQDtWHKATQKGDPVAILKRQLEE |
| Q9P2J5 | T721 | Sugiyama | LARS1 KIAA1352 LARS | PTAVRANGHLLLNSEKMSKstGNFLtLtQAIDKFSADGMRL |
| Q9P2J5 | T726 | Sugiyama | LARS1 KIAA1352 LARS | ANGHLLLNSEKMSKstGNFLtLtQAIDKFSADGMRLALADA |
| Q9UBQ5 | T28 | Sugiyama | EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001 | RANVGKLLKGIDRyNPENLAtLERYVETQAKENAyDLEANL |
| Q9UBR2 | S195 | Sugiyama | CTSZ | EFKECHAIRNYTLWRVGDYGsLSGREKMMAEIYANGPISCG |
| Q9UBR2 | T172 | Sugiyama | CTSZ | ETCNNYQAKDQECDKFNQCGtCNEFKECHAIRNYTLWRVGD |
| Q9UHD1 | T204 | Sugiyama | CHORDC1 CHP1 | IFHEGMKYWSCCRRKtsDFNtFLAQEGCtKGKHMWTKKDAG |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UPQ0 | S204 | Sugiyama | LIMCH1 KIAA1102 | DsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVVLRG |
| Q9UQ35 | S1054 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sLCAGVKsstPPGEsyFGVssLQLKGQsQtsPDHRsDtssP |
| Q9UQ35 | T1043 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | DsLVQsCPGsLsLCAGVKsstPPGEsyFGVssLQLKGQsQt |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9Y230 | T194 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | LGTKMIESLTKDKVQAGDVItIDKAtGKISKLGRSFTRARD |
| Q9Y230 | T199 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | IESLTKDKVQAGDVItIDKAtGKISKLGRSFTRARDyDAMG |
| Q9Y266 | S136 | Sugiyama | NUDC | QLEIDQKKDAENHEAQLKNGsLDsPGKQDtEEDEEEDEKDK |
| Q9Y266 | T145 | Sugiyama | NUDC | AENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKLKPNLGN |
| Q9Y281 | T88 | Sugiyama | CFL2 | YtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPES |
| Q9Y281 | T91 | Sugiyama | CFL2 | FVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y295 | T62 | Sugiyama | DRG1 NEDD3 | LITPKGGGGGGPGEGFDVAKtGDARIGFVGFPSVGKSTLLS |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | T100 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | ELLEEICDRMKEyGEQIDPstHRKNYVRVVGRNGEssELDL |
| Q9Y2T7 | T124 | Sugiyama | YBX2 CSDA3 MSY2 | RNGyGFINRNDtKEDVFVHQtAIKRNNPRKFLRsVGDGEtV |
| Q9Y2W1 | T227 | Sugiyama | THRAP3 BCLAF2 TRAP150 | sGGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRER |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y2X3 | S434 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | AKTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQVDKEDEI |
| Q9Y2X3 | T427 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | SGTGKALAKTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQ |
| Q9Y2X3 | T435 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | KTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQVDKEDEIT |
| Q9Y2X3 | Y428 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | GTGKALAKTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQV |
| Q9Y305 | S424 | Sugiyama | ACOT9 CGI-16 | VFPKTYGESMLYLDGQRHFNsMSGPAtLRKDYLVEP_____ |
| Q9Y305 | T430 | Sugiyama | ACOT9 CGI-16 | GESMLYLDGQRHFNsMSGPAtLRKDYLVEP___________ |
| Q9Y383 | S347 | Sugiyama | LUC7L2 CGI-59 CGI-74 | SRERSKRRSSKERFRDQDLAsCDRDRssRDRSPRDRDRKDK |
| Q9Y3F4 | S230 | Sugiyama | STRAP MAWD UNRIP | SAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDFKLyKy |
| Q9Y3F4 | T225 | Sugiyama | STRAP MAWD UNRIP | SIAFHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDF |
| Q9Y3F4 | T48 | Sugiyama | STRAP MAWD UNRIP | YGYFLISACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLN |
| Q9Y3F4 | T54 | Sugiyama | STRAP MAWD UNRIP | SACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLNKDATKA |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y4F1 | S23 | Sugiyama | FARP1 CDEP PLEKHC2 | EIEQRPTPGsRLGAPENsGIstLERGQKPPPtPSGKLVSIK |
| Q9Y4L1 | S461 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | VVYPILVEFTREVEEEPGIHsLKHNKRVLFSRMGPYPQRKV |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y5L4 | T79 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | DNSEQKCIAMCMDRyMDAWNtVsRAYNSRLQRERANM____ |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y696 | T233 | Sugiyama | CLIC4 | EMTGIWRYLtNAysRDEFtNtCPsDKEVEIAysDVAKRLTK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 1.475524e-07 | 6.831 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.375739e-07 | 6.132 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.117469e-06 | 5.952 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.857529e-06 | 5.544 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.462327e-06 | 5.461 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.257562e-06 | 5.279 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.926235e-05 | 4.715 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.297690e-05 | 4.639 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.272906e-05 | 4.643 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.501940e-05 | 4.602 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.158400e-05 | 4.381 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.005346e-05 | 4.045 | 1 | 1 |
| Cellular Senescence | R-HSA-2559583 | 1.034887e-04 | 3.985 | 1 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.195918e-04 | 3.922 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.463523e-04 | 3.835 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.463523e-04 | 3.835 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.663253e-04 | 3.779 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.738221e-04 | 3.760 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.213925e-04 | 3.655 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.243645e-04 | 3.649 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.358721e-04 | 3.474 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.358721e-04 | 3.474 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.488053e-04 | 3.457 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.017539e-04 | 3.396 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.238175e-04 | 3.373 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.600883e-04 | 3.252 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.831687e-04 | 3.234 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.917179e-04 | 3.228 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.528832e-04 | 3.185 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.369367e-04 | 3.133 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.714164e-04 | 3.113 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.287559e-04 | 3.082 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.096326e-04 | 3.092 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 9.666312e-04 | 3.015 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.356256e-04 | 3.029 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.851727e-04 | 3.006 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.078306e-03 | 2.967 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.082410e-03 | 2.966 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.181938e-03 | 2.927 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.225337e-03 | 2.912 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.341221e-03 | 2.872 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.352292e-03 | 2.869 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.388341e-03 | 2.858 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.643380e-03 | 2.784 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.644730e-03 | 2.784 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.686617e-03 | 2.773 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.891512e-03 | 2.723 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.860840e-03 | 2.730 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.935569e-03 | 2.713 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.935569e-03 | 2.713 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.162905e-03 | 2.665 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.369436e-03 | 2.625 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.279006e-03 | 2.642 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.140726e-03 | 2.503 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.991341e-03 | 2.524 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.989549e-03 | 2.524 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.989549e-03 | 2.524 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.501541e-03 | 2.456 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.577521e-03 | 2.446 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.410763e-03 | 2.467 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.592085e-03 | 2.445 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.709033e-03 | 2.431 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.723526e-03 | 2.429 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.008678e-03 | 2.397 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.008678e-03 | 2.397 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.916536e-03 | 2.407 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.038636e-03 | 2.394 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.510825e-03 | 2.346 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.549457e-03 | 2.342 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.921866e-03 | 2.308 | 1 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.731124e-03 | 2.325 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.058502e-03 | 2.296 | 1 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.272122e-03 | 2.278 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.410126e-03 | 2.267 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.459347e-03 | 2.263 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.356553e-03 | 2.271 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.452358e-03 | 2.263 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.651309e-03 | 2.248 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.984195e-03 | 2.223 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.897932e-03 | 2.229 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.137306e-03 | 2.212 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.173375e-03 | 2.209 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.137306e-03 | 2.212 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.856768e-03 | 2.232 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.249717e-03 | 2.204 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.603418e-03 | 2.180 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.885670e-03 | 2.162 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.464193e-03 | 2.127 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.464193e-03 | 2.127 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.464193e-03 | 2.127 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.464193e-03 | 2.127 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.392012e-03 | 2.131 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.470668e-03 | 2.127 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.156210e-03 | 2.089 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.356254e-03 | 2.078 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.369131e-03 | 2.077 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.541140e-03 | 2.020 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.836572e-03 | 2.007 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.081175e-02 | 1.966 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.081175e-02 | 1.966 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.021082e-02 | 1.991 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.035057e-02 | 1.985 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.134783e-02 | 1.945 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.142672e-02 | 1.942 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.142672e-02 | 1.942 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.187718e-02 | 1.925 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.197311e-02 | 1.922 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.197311e-02 | 1.922 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.197311e-02 | 1.922 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.333683e-02 | 1.875 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.221729e-02 | 1.913 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.246858e-02 | 1.904 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.336278e-02 | 1.874 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.362472e-02 | 1.866 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.479257e-02 | 1.830 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.484794e-02 | 1.828 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.505562e-02 | 1.822 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.536124e-02 | 1.814 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.543875e-02 | 1.811 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.647933e-02 | 1.783 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.647933e-02 | 1.783 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.681545e-02 | 1.774 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.743965e-02 | 1.758 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.854673e-02 | 1.732 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.879065e-02 | 1.726 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.979247e-02 | 1.703 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.317284e-02 | 1.635 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.317284e-02 | 1.635 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.388554e-02 | 1.622 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.553879e-02 | 1.593 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.553879e-02 | 1.593 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.546201e-02 | 1.594 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.699680e-02 | 1.569 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.665449e-02 | 1.574 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.721941e-02 | 1.565 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.789114e-02 | 1.555 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.794810e-02 | 1.554 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.846014e-02 | 1.546 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.868767e-02 | 1.542 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.899716e-02 | 1.538 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.021951e-02 | 1.520 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.034682e-02 | 1.518 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.180600e-02 | 1.497 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.231586e-02 | 1.491 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.234347e-02 | 1.490 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.436849e-02 | 1.464 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.774504e-02 | 1.423 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.385014e-02 | 1.470 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.385014e-02 | 1.470 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.317812e-02 | 1.479 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.872915e-02 | 1.412 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.872915e-02 | 1.412 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.968732e-02 | 1.401 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 4.003958e-02 | 1.398 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 4.003958e-02 | 1.398 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.136367e-02 | 1.383 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.174161e-02 | 1.379 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.174161e-02 | 1.379 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.220648e-02 | 1.375 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.220648e-02 | 1.375 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.305782e-02 | 1.366 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.398624e-02 | 1.357 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.982482e-02 | 1.303 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.551380e-02 | 1.342 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.305782e-02 | 1.366 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.982482e-02 | 1.303 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.982482e-02 | 1.303 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.305782e-02 | 1.366 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 4.398624e-02 | 1.357 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.368622e-02 | 1.360 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.897139e-02 | 1.310 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.305782e-02 | 1.366 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.651547e-02 | 1.332 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.790301e-02 | 1.320 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.773627e-02 | 1.321 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.305782e-02 | 1.366 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.615095e-02 | 1.336 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.116571e-02 | 1.291 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.307694e-02 | 1.275 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.307694e-02 | 1.275 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.392240e-02 | 1.268 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.677025e-02 | 1.246 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.698678e-02 | 1.244 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.879444e-02 | 1.231 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.879444e-02 | 1.231 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.942298e-02 | 1.226 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.185070e-02 | 1.209 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.185070e-02 | 1.209 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.225909e-02 | 1.206 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.285768e-02 | 1.202 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.382799e-02 | 1.195 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.523647e-02 | 1.124 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.944160e-02 | 1.158 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.692645e-02 | 1.174 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.692645e-02 | 1.174 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.851924e-02 | 1.164 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.347343e-02 | 1.197 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.576707e-02 | 1.121 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.576707e-02 | 1.121 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.238851e-02 | 1.140 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 6.382799e-02 | 1.195 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.944160e-02 | 1.158 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.848636e-02 | 1.164 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.523647e-02 | 1.124 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.523647e-02 | 1.124 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.908034e-02 | 1.161 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.664628e-02 | 1.116 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.770223e-02 | 1.110 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.770223e-02 | 1.110 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.770223e-02 | 1.110 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 7.847832e-02 | 1.105 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 7.847832e-02 | 1.105 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 7.847832e-02 | 1.105 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 7.847832e-02 | 1.105 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 7.847832e-02 | 1.105 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 7.847832e-02 | 1.105 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 7.847832e-02 | 1.105 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.928177e-02 | 1.101 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 8.723270e-02 | 1.059 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 9.975146e-02 | 1.001 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 9.975146e-02 | 1.001 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 9.975146e-02 | 1.001 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.198401e-02 | 1.036 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.339562e-02 | 1.079 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.537395e-02 | 1.021 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.416458e-02 | 1.075 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 8.203960e-02 | 1.086 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 8.723270e-02 | 1.059 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 9.975146e-02 | 1.001 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.545464e-02 | 1.068 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.416458e-02 | 1.075 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.928760e-02 | 1.049 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.255020e-02 | 1.034 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.203960e-02 | 1.086 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.339562e-02 | 1.079 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.438568e-02 | 1.074 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.906800e-02 | 1.004 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.723270e-02 | 1.059 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.975146e-02 | 1.001 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.928760e-02 | 1.049 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.475769e-02 | 1.023 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.276813e-02 | 1.082 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.883782e-02 | 1.051 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.198401e-02 | 1.036 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 9.975146e-02 | 1.001 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.000916e-01 | 1.000 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 1.000916e-01 | 1.000 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.000916e-01 | 1.000 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.000916e-01 | 1.000 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.000916e-01 | 1.000 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.013358e-01 | 0.994 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.016501e-01 | 0.993 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.022962e-01 | 0.990 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.026898e-01 | 0.988 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.031346e-01 | 0.987 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.153801e-01 | 0.938 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 1.153801e-01 | 0.938 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.153801e-01 | 0.938 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.153801e-01 | 0.938 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.153801e-01 | 0.938 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.508064e-01 | 0.822 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.508064e-01 | 0.822 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.508064e-01 | 0.822 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.508064e-01 | 0.822 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.508064e-01 | 0.822 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.508064e-01 | 0.822 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.508064e-01 | 0.822 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.508064e-01 | 0.822 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.508064e-01 | 0.822 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.508064e-01 | 0.822 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.508064e-01 | 0.822 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.848160e-01 | 0.733 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.848160e-01 | 0.733 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.848160e-01 | 0.733 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.174656e-01 | 0.663 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.174656e-01 | 0.663 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.174656e-01 | 0.663 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.174656e-01 | 0.663 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.174656e-01 | 0.663 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.174656e-01 | 0.663 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.174656e-01 | 0.663 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.127318e-01 | 0.948 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.127318e-01 | 0.948 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 2.488094e-01 | 0.604 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.488094e-01 | 0.604 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.488094e-01 | 0.604 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.488094e-01 | 0.604 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.261170e-01 | 0.899 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.261170e-01 | 0.899 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.398537e-01 | 0.854 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.398537e-01 | 0.854 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.788996e-01 | 0.555 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.788996e-01 | 0.555 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.788996e-01 | 0.555 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.538925e-01 | 0.813 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.681874e-01 | 0.774 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.077862e-01 | 0.512 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.077862e-01 | 0.512 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.084741e-01 | 0.965 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.084741e-01 | 0.965 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.826953e-01 | 0.738 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.826953e-01 | 0.738 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.826953e-01 | 0.738 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.260090e-01 | 0.900 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.973765e-01 | 0.705 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.973765e-01 | 0.705 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.355173e-01 | 0.474 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.355173e-01 | 0.474 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.355173e-01 | 0.474 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.271128e-01 | 0.644 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.621391e-01 | 0.441 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.621391e-01 | 0.441 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.621391e-01 | 0.441 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.621391e-01 | 0.441 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.621391e-01 | 0.441 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.736872e-01 | 0.760 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.285524e-01 | 0.891 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.876959e-01 | 0.412 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.876959e-01 | 0.412 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.876959e-01 | 0.412 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.876959e-01 | 0.412 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.876959e-01 | 0.412 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.940025e-01 | 0.712 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.721740e-01 | 0.565 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.043722e-01 | 0.690 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.148657e-01 | 0.668 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.872047e-01 | 0.542 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.122302e-01 | 0.385 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.254701e-01 | 0.647 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.177914e-01 | 0.929 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.022005e-01 | 0.520 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.022005e-01 | 0.520 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.278673e-01 | 0.893 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.320037e-01 | 0.479 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 2.687493e-01 | 0.571 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.467738e-01 | 0.460 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.406327e-01 | 0.619 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.017884e-01 | 0.520 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.903659e-01 | 0.409 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 3.903659e-01 | 0.409 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.345865e-01 | 0.630 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.341206e-01 | 0.873 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 1.755005e-01 | 0.756 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.178102e-01 | 0.662 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.178102e-01 | 0.662 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.186970e-01 | 0.378 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.305954e-01 | 0.481 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.305954e-01 | 0.481 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.889079e-01 | 0.539 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.581085e-01 | 0.446 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.856011e-01 | 0.414 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.038531e-01 | 0.394 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.670362e-01 | 0.435 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.880494e-01 | 0.411 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.958178e-01 | 0.403 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.958178e-01 | 0.403 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.759691e-01 | 0.425 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.639690e-01 | 0.785 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.872047e-01 | 0.542 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.872047e-01 | 0.542 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.906980e-01 | 0.720 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.271128e-01 | 0.644 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.271128e-01 | 0.644 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.114752e-01 | 0.953 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.178102e-01 | 0.662 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.043722e-01 | 0.690 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.872047e-01 | 0.542 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 1.840531e-01 | 0.735 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.671340e-01 | 0.573 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.415600e-01 | 0.617 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.423615e-01 | 0.847 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.800456e-01 | 0.420 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.876959e-01 | 0.412 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.563535e-01 | 0.806 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.038531e-01 | 0.394 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.522703e-01 | 0.817 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.747058e-01 | 0.758 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.621391e-01 | 0.441 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.004018e-01 | 0.522 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.361727e-01 | 0.627 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.640318e-01 | 0.439 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.040346e-01 | 0.394 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.637685e-01 | 0.786 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.123115e-01 | 0.505 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.953386e-01 | 0.709 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.882257e-01 | 0.725 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.240670e-01 | 0.650 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.240670e-01 | 0.650 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.872047e-01 | 0.542 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.941258e-01 | 0.531 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.650840e-01 | 0.782 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.993963e-01 | 0.399 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.101974e-01 | 0.387 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.174656e-01 | 0.663 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.488094e-01 | 0.604 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.488094e-01 | 0.604 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 2.488094e-01 | 0.604 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.621391e-01 | 0.441 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.525080e-01 | 0.817 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.350050e-01 | 0.475 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.460717e-01 | 0.461 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.764475e-01 | 0.424 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.670362e-01 | 0.435 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.739139e-01 | 0.562 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.121938e-01 | 0.673 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.975598e-01 | 0.704 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.975598e-01 | 0.704 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.975598e-01 | 0.704 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 1.351337e-01 | 0.869 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.969717e-01 | 0.527 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.444778e-01 | 0.840 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.464250e-01 | 0.834 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.082804e-01 | 0.511 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.578241e-01 | 0.589 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.876959e-01 | 0.412 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.421018e-01 | 0.616 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.536475e-01 | 0.596 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.186970e-01 | 0.378 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.432642e-01 | 0.844 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.579505e-01 | 0.588 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.153801e-01 | 0.938 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.153801e-01 | 0.938 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.153801e-01 | 0.938 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.127318e-01 | 0.948 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.488094e-01 | 0.604 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.261170e-01 | 0.899 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 2.788996e-01 | 0.555 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.538925e-01 | 0.813 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 3.077862e-01 | 0.512 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.355173e-01 | 0.474 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.444778e-01 | 0.840 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.081113e-01 | 0.966 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.621391e-01 | 0.441 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.122302e-01 | 0.385 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.122302e-01 | 0.385 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.122302e-01 | 0.385 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.122302e-01 | 0.385 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.122302e-01 | 0.385 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.736750e-01 | 0.760 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.254701e-01 | 0.647 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.469614e-01 | 0.607 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.046123e-01 | 0.393 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.546002e-01 | 0.594 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.533927e-01 | 0.814 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.186970e-01 | 0.378 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 3.350050e-01 | 0.475 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.129426e-01 | 0.384 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.721740e-01 | 0.565 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.467738e-01 | 0.460 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.750587e-01 | 0.561 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.817301e-01 | 0.741 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.030105e-01 | 0.395 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.540274e-01 | 0.812 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.254701e-01 | 0.647 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.040346e-01 | 0.394 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.968647e-01 | 0.706 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.817301e-01 | 0.741 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.488094e-01 | 0.604 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.621391e-01 | 0.441 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.148657e-01 | 0.668 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.017884e-01 | 0.520 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.017884e-01 | 0.520 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.020217e-01 | 0.695 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.839532e-01 | 0.735 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.968647e-01 | 0.706 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.241205e-01 | 0.489 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.672817e-01 | 0.435 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.504614e-01 | 0.823 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.291657e-01 | 0.483 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.658027e-01 | 0.780 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.658027e-01 | 0.780 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.239294e-01 | 0.490 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.368285e-01 | 0.473 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.681874e-01 | 0.774 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.355173e-01 | 0.474 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.355173e-01 | 0.474 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.876959e-01 | 0.412 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.122302e-01 | 0.385 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.980207e-01 | 0.703 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.314404e-01 | 0.636 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.441678e-01 | 0.841 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.903659e-01 | 0.409 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 3.032035e-01 | 0.518 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.958872e-01 | 0.529 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.545528e-01 | 0.811 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.973765e-01 | 0.705 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.637685e-01 | 0.786 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.074519e-01 | 0.969 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.680228e-01 | 0.775 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.233219e-01 | 0.651 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.312208e-01 | 0.480 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.618511e-01 | 0.441 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.471141e-01 | 0.832 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.712958e-01 | 0.766 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.760726e-01 | 0.754 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.760726e-01 | 0.754 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.285524e-01 | 0.891 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.285524e-01 | 0.891 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.228085e-01 | 0.911 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.350050e-01 | 0.475 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.153801e-01 | 0.938 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.848160e-01 | 0.733 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.174656e-01 | 0.663 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.788996e-01 | 0.555 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.355173e-01 | 0.474 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.621391e-01 | 0.441 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.621391e-01 | 0.441 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.621391e-01 | 0.441 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.215679e-01 | 0.915 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.421018e-01 | 0.616 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.876959e-01 | 0.412 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.361727e-01 | 0.627 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.900336e-01 | 0.721 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.463885e-01 | 0.608 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.941258e-01 | 0.531 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.941258e-01 | 0.531 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.046123e-01 | 0.393 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.123115e-01 | 0.505 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.166348e-01 | 0.380 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.658027e-01 | 0.780 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.128541e-01 | 0.505 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.104450e-01 | 0.957 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.907422e-01 | 0.536 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.167662e-01 | 0.664 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.118253e-01 | 0.385 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.280270e-01 | 0.642 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.769783e-01 | 0.558 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.618511e-01 | 0.441 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.841385e-01 | 0.416 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 1.848160e-01 | 0.733 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.077862e-01 | 0.512 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.876959e-01 | 0.412 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.614433e-01 | 0.792 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.792988e-01 | 0.554 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.079632e-01 | 0.389 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.017884e-01 | 0.520 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.571208e-01 | 0.447 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.360660e-01 | 0.866 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.791336e-01 | 0.421 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.464517e-01 | 0.460 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.445963e-01 | 0.612 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.174656e-01 | 0.663 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.488094e-01 | 0.604 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.488094e-01 | 0.604 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.398537e-01 | 0.854 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.788996e-01 | 0.555 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.681874e-01 | 0.774 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.973765e-01 | 0.705 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.355173e-01 | 0.474 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.355173e-01 | 0.474 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.355173e-01 | 0.474 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.621391e-01 | 0.441 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.285524e-01 | 0.891 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.285524e-01 | 0.891 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.357001e-01 | 0.867 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.876959e-01 | 0.412 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.022005e-01 | 0.520 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.226946e-01 | 0.911 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.123115e-01 | 0.505 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.186970e-01 | 0.378 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.023980e-01 | 0.694 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.947783e-01 | 0.404 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.903659e-01 | 0.409 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 1.498875e-01 | 0.824 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.759691e-01 | 0.425 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.614338e-01 | 0.442 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.397602e-01 | 0.469 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 2.361727e-01 | 0.627 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.260090e-01 | 0.900 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.260090e-01 | 0.900 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.538334e-01 | 0.595 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.421018e-01 | 0.616 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.876959e-01 | 0.412 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.350050e-01 | 0.475 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.062870e-01 | 0.974 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.460717e-01 | 0.461 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.681441e-01 | 0.434 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.120734e-01 | 0.674 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.127318e-01 | 0.948 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.009812e-01 | 0.397 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.197510e-01 | 0.377 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.488094e-01 | 0.604 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.788996e-01 | 0.555 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.788996e-01 | 0.555 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.538925e-01 | 0.813 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.077862e-01 | 0.512 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.077862e-01 | 0.512 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.121938e-01 | 0.673 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.147523e-01 | 0.940 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.876959e-01 | 0.412 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.876959e-01 | 0.412 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.816731e-01 | 0.741 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.171400e-01 | 0.499 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.239294e-01 | 0.490 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.085383e-01 | 0.511 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.130937e-01 | 0.504 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.240670e-01 | 0.650 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.728894e-01 | 0.762 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.826953e-01 | 0.738 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.721740e-01 | 0.565 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.872047e-01 | 0.542 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.485419e-01 | 0.828 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.178579e-01 | 0.929 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.719339e-01 | 0.765 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.635547e-01 | 0.579 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.186970e-01 | 0.378 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.215679e-01 | 0.915 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.122302e-01 | 0.385 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.671340e-01 | 0.573 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.350050e-01 | 0.475 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.993979e-01 | 0.524 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.721740e-01 | 0.565 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.958872e-01 | 0.529 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.397602e-01 | 0.469 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.460717e-01 | 0.461 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.026164e-01 | 0.519 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 2.488094e-01 | 0.604 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.421018e-01 | 0.616 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.876959e-01 | 0.412 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.122302e-01 | 0.385 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.367608e-01 | 0.473 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.681441e-01 | 0.434 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.917628e-01 | 0.717 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.939778e-01 | 0.532 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.872047e-01 | 0.542 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.460717e-01 | 0.461 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.275769e-01 | 0.643 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.876959e-01 | 0.412 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.022005e-01 | 0.520 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 3.672817e-01 | 0.435 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.421018e-01 | 0.616 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.759691e-01 | 0.425 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.009812e-01 | 0.397 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.872047e-01 | 0.542 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.171178e-01 | 0.931 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.421018e-01 | 0.616 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.614338e-01 | 0.442 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.903659e-01 | 0.409 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.044317e-01 | 0.689 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.022005e-01 | 0.520 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.361727e-01 | 0.627 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.625767e-01 | 0.441 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.460717e-01 | 0.461 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.598504e-01 | 0.444 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.173763e-01 | 0.379 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.437295e-01 | 0.842 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.961903e-01 | 0.707 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.345865e-01 | 0.630 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.614338e-01 | 0.442 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.226074e-01 | 0.374 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.279095e-01 | 0.369 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.299814e-01 | 0.367 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 4.317008e-01 | 0.365 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.326103e-01 | 0.364 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.326103e-01 | 0.364 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.326103e-01 | 0.364 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.338183e-01 | 0.363 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.357829e-01 | 0.361 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.357829e-01 | 0.361 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.357829e-01 | 0.361 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.357829e-01 | 0.361 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.357829e-01 | 0.361 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.358285e-01 | 0.361 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.358285e-01 | 0.361 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.358285e-01 | 0.361 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.388421e-01 | 0.358 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.388421e-01 | 0.358 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.400142e-01 | 0.357 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.421810e-01 | 0.354 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.439614e-01 | 0.353 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.439614e-01 | 0.353 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.439614e-01 | 0.353 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.439614e-01 | 0.353 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.439614e-01 | 0.353 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.439614e-01 | 0.353 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.459665e-01 | 0.351 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.463432e-01 | 0.350 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.463432e-01 | 0.350 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.463432e-01 | 0.350 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.463432e-01 | 0.350 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.463432e-01 | 0.350 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.463432e-01 | 0.350 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.489593e-01 | 0.348 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.489593e-01 | 0.348 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.515906e-01 | 0.345 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.545220e-01 | 0.342 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.545220e-01 | 0.342 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.583932e-01 | 0.339 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.583932e-01 | 0.339 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.583932e-01 | 0.339 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.583932e-01 | 0.339 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.583932e-01 | 0.339 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.583932e-01 | 0.339 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.583932e-01 | 0.339 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.583932e-01 | 0.339 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.583932e-01 | 0.339 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.594284e-01 | 0.338 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.594284e-01 | 0.338 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.594284e-01 | 0.338 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.594284e-01 | 0.338 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.598879e-01 | 0.337 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.598879e-01 | 0.337 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.667092e-01 | 0.331 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.667092e-01 | 0.331 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.732374e-01 | 0.325 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.732374e-01 | 0.325 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.732374e-01 | 0.325 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.732374e-01 | 0.325 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.753846e-01 | 0.323 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.753846e-01 | 0.323 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.800987e-01 | 0.319 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.800987e-01 | 0.319 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.800987e-01 | 0.319 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.800987e-01 | 0.319 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.800987e-01 | 0.319 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.800987e-01 | 0.319 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.800987e-01 | 0.319 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.800987e-01 | 0.319 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.800987e-01 | 0.319 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.800987e-01 | 0.319 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.800987e-01 | 0.319 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.800987e-01 | 0.319 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.800987e-01 | 0.319 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.800987e-01 | 0.319 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.800987e-01 | 0.319 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.800987e-01 | 0.319 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.800987e-01 | 0.319 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.813735e-01 | 0.318 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.827380e-01 | 0.316 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.827380e-01 | 0.316 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.842493e-01 | 0.315 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.842493e-01 | 0.315 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.856772e-01 | 0.314 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.856772e-01 | 0.314 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.856772e-01 | 0.314 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.862975e-01 | 0.313 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.863857e-01 | 0.313 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 4.863857e-01 | 0.313 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 4.931767e-01 | 0.307 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.958716e-01 | 0.305 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.958716e-01 | 0.305 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 4.958716e-01 | 0.305 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.958716e-01 | 0.305 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.980843e-01 | 0.303 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.989924e-01 | 0.302 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.993273e-01 | 0.302 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.993273e-01 | 0.302 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.009356e-01 | 0.300 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.009356e-01 | 0.300 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.009356e-01 | 0.300 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.009356e-01 | 0.300 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.009356e-01 | 0.300 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.009356e-01 | 0.300 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.009356e-01 | 0.300 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.009356e-01 | 0.300 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.009356e-01 | 0.300 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.009356e-01 | 0.300 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.054684e-01 | 0.296 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.059639e-01 | 0.296 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.079385e-01 | 0.294 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 5.120579e-01 | 0.291 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.120579e-01 | 0.291 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.120579e-01 | 0.291 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.186019e-01 | 0.285 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.207695e-01 | 0.283 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.209386e-01 | 0.283 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.209386e-01 | 0.283 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.209386e-01 | 0.283 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.209386e-01 | 0.283 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.209386e-01 | 0.283 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.209386e-01 | 0.283 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.209386e-01 | 0.283 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.209386e-01 | 0.283 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.209386e-01 | 0.283 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.209386e-01 | 0.283 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.227946e-01 | 0.282 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.245734e-01 | 0.280 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.245734e-01 | 0.280 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.245734e-01 | 0.280 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.251949e-01 | 0.280 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.258277e-01 | 0.279 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.258277e-01 | 0.279 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.258277e-01 | 0.279 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.258277e-01 | 0.279 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.258277e-01 | 0.279 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 5.258277e-01 | 0.279 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.259934e-01 | 0.279 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.259934e-01 | 0.279 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.282341e-01 | 0.277 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 5.294608e-01 | 0.276 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.353708e-01 | 0.271 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.355927e-01 | 0.271 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.355927e-01 | 0.271 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.356470e-01 | 0.271 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.368708e-01 | 0.270 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.401410e-01 | 0.267 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.401410e-01 | 0.267 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.401410e-01 | 0.267 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.401410e-01 | 0.267 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.401410e-01 | 0.267 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.401410e-01 | 0.267 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.401410e-01 | 0.267 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.401410e-01 | 0.267 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.401410e-01 | 0.267 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.401410e-01 | 0.267 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.401410e-01 | 0.267 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.430064e-01 | 0.265 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.430464e-01 | 0.265 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.436450e-01 | 0.265 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.452426e-01 | 0.263 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.452426e-01 | 0.263 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 5.489473e-01 | 0.260 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.489473e-01 | 0.260 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.495727e-01 | 0.260 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.503106e-01 | 0.259 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.546834e-01 | 0.256 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.575581e-01 | 0.254 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.575581e-01 | 0.254 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.585749e-01 | 0.253 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.585749e-01 | 0.253 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.585749e-01 | 0.253 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.585749e-01 | 0.253 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.585749e-01 | 0.253 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.585749e-01 | 0.253 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.585749e-01 | 0.253 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.585749e-01 | 0.253 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.585749e-01 | 0.253 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.585749e-01 | 0.253 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.585749e-01 | 0.253 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.585749e-01 | 0.253 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.608010e-01 | 0.251 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.718768e-01 | 0.243 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.734305e-01 | 0.242 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.762709e-01 | 0.239 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.762709e-01 | 0.239 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.762709e-01 | 0.239 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 5.762709e-01 | 0.239 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.762709e-01 | 0.239 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.762709e-01 | 0.239 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.762709e-01 | 0.239 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.762709e-01 | 0.239 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.789452e-01 | 0.237 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.793930e-01 | 0.237 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.838322e-01 | 0.234 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.838341e-01 | 0.234 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.838341e-01 | 0.234 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.838341e-01 | 0.234 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.838341e-01 | 0.234 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.838341e-01 | 0.234 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.932586e-01 | 0.227 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.932586e-01 | 0.227 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.932586e-01 | 0.227 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.932586e-01 | 0.227 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.948011e-01 | 0.226 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.997710e-01 | 0.222 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.059633e-01 | 0.218 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.059633e-01 | 0.218 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.059633e-01 | 0.218 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.069370e-01 | 0.217 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.072869e-01 | 0.217 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.095661e-01 | 0.215 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.095661e-01 | 0.215 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.095661e-01 | 0.215 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.095661e-01 | 0.215 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.095661e-01 | 0.215 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.095661e-01 | 0.215 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.095661e-01 | 0.215 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.095661e-01 | 0.215 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.095661e-01 | 0.215 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.095661e-01 | 0.215 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.134501e-01 | 0.212 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.142922e-01 | 0.212 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.180297e-01 | 0.209 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.180297e-01 | 0.209 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.180297e-01 | 0.209 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.180297e-01 | 0.209 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.188755e-01 | 0.208 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.218977e-01 | 0.206 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.252209e-01 | 0.204 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.252209e-01 | 0.204 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.252209e-01 | 0.204 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.252209e-01 | 0.204 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.252209e-01 | 0.204 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.252209e-01 | 0.204 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.252209e-01 | 0.204 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.252209e-01 | 0.204 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.252209e-01 | 0.204 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.252209e-01 | 0.204 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.271884e-01 | 0.203 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.271884e-01 | 0.203 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.297522e-01 | 0.201 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.349433e-01 | 0.197 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.374634e-01 | 0.196 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.374634e-01 | 0.196 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.375534e-01 | 0.195 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.402488e-01 | 0.194 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.402488e-01 | 0.194 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.402488e-01 | 0.194 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.402488e-01 | 0.194 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.402488e-01 | 0.194 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.402488e-01 | 0.194 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.402488e-01 | 0.194 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.402488e-01 | 0.194 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.432022e-01 | 0.192 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.436547e-01 | 0.191 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.452152e-01 | 0.190 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.475148e-01 | 0.189 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.475148e-01 | 0.189 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.507215e-01 | 0.187 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.513284e-01 | 0.186 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.529534e-01 | 0.185 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.546750e-01 | 0.184 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.546750e-01 | 0.184 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.546750e-01 | 0.184 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.546750e-01 | 0.184 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.546750e-01 | 0.184 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.546750e-01 | 0.184 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.573440e-01 | 0.182 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.573440e-01 | 0.182 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.573440e-01 | 0.182 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 6.647761e-01 | 0.177 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.647761e-01 | 0.177 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.669526e-01 | 0.176 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.669526e-01 | 0.176 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.685236e-01 | 0.175 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.685236e-01 | 0.175 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.685236e-01 | 0.175 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.685236e-01 | 0.175 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.685236e-01 | 0.175 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.763426e-01 | 0.170 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.763426e-01 | 0.170 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.763426e-01 | 0.170 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.763426e-01 | 0.170 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.763426e-01 | 0.170 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.780457e-01 | 0.169 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.809400e-01 | 0.167 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.818176e-01 | 0.166 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.818176e-01 | 0.166 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.818176e-01 | 0.166 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.818176e-01 | 0.166 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 6.818176e-01 | 0.166 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.818176e-01 | 0.166 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.818176e-01 | 0.166 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.825032e-01 | 0.166 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.829905e-01 | 0.166 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.855159e-01 | 0.164 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.855159e-01 | 0.164 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.880334e-01 | 0.162 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.895982e-01 | 0.161 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.911372e-01 | 0.160 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.937506e-01 | 0.159 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.944750e-01 | 0.158 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.944750e-01 | 0.158 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.945792e-01 | 0.158 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.945792e-01 | 0.158 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 6.945792e-01 | 0.158 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.945792e-01 | 0.158 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.945792e-01 | 0.158 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.945792e-01 | 0.158 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.955483e-01 | 0.158 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.975397e-01 | 0.156 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.975397e-01 | 0.156 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.990389e-01 | 0.155 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.032221e-01 | 0.153 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.032221e-01 | 0.153 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.032221e-01 | 0.153 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.068298e-01 | 0.151 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.068298e-01 | 0.151 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.068298e-01 | 0.151 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.068298e-01 | 0.151 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.117599e-01 | 0.148 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.117599e-01 | 0.148 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.117599e-01 | 0.148 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.117599e-01 | 0.148 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.185896e-01 | 0.144 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.185896e-01 | 0.144 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.185896e-01 | 0.144 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.185896e-01 | 0.144 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.185896e-01 | 0.144 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.185896e-01 | 0.144 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.195763e-01 | 0.143 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.200911e-01 | 0.143 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.200911e-01 | 0.143 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.221941e-01 | 0.141 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.282185e-01 | 0.138 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.282185e-01 | 0.138 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.298785e-01 | 0.137 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.298785e-01 | 0.137 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.298785e-01 | 0.137 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.298785e-01 | 0.137 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.298785e-01 | 0.137 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.298785e-01 | 0.137 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.319711e-01 | 0.136 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.319711e-01 | 0.136 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.361450e-01 | 0.133 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.361450e-01 | 0.133 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.361450e-01 | 0.133 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.361450e-01 | 0.133 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.407151e-01 | 0.130 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.407151e-01 | 0.130 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.407151e-01 | 0.130 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.407151e-01 | 0.130 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.407151e-01 | 0.130 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.407151e-01 | 0.130 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.407151e-01 | 0.130 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.407151e-01 | 0.130 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.407151e-01 | 0.130 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.417185e-01 | 0.130 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.485632e-01 | 0.126 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.511177e-01 | 0.124 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.511177e-01 | 0.124 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.511177e-01 | 0.124 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.511177e-01 | 0.124 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.511177e-01 | 0.124 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.514078e-01 | 0.124 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.535509e-01 | 0.123 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.587502e-01 | 0.120 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.587502e-01 | 0.120 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.611035e-01 | 0.119 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.611035e-01 | 0.119 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 7.611035e-01 | 0.119 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.611035e-01 | 0.119 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 7.611035e-01 | 0.119 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.611035e-01 | 0.119 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.611035e-01 | 0.119 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.634451e-01 | 0.117 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.659044e-01 | 0.116 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 7.659044e-01 | 0.116 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.693669e-01 | 0.114 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.706892e-01 | 0.113 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.706892e-01 | 0.113 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.706892e-01 | 0.113 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.706892e-01 | 0.113 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.706892e-01 | 0.113 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.728735e-01 | 0.112 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.728735e-01 | 0.112 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.728735e-01 | 0.112 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.796609e-01 | 0.108 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.796609e-01 | 0.108 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.796609e-01 | 0.108 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.798909e-01 | 0.108 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.862699e-01 | 0.104 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 7.887238e-01 | 0.103 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.887238e-01 | 0.103 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.887238e-01 | 0.103 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.972028e-01 | 0.098 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.972028e-01 | 0.098 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.972028e-01 | 0.098 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.972028e-01 | 0.098 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.972028e-01 | 0.098 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.972028e-01 | 0.098 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.972028e-01 | 0.098 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.972028e-01 | 0.098 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.989665e-01 | 0.097 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.015356e-01 | 0.096 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.036734e-01 | 0.095 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.050608e-01 | 0.094 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.053421e-01 | 0.094 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.053421e-01 | 0.094 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.053421e-01 | 0.094 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.053421e-01 | 0.094 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.053421e-01 | 0.094 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.053421e-01 | 0.094 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.077239e-01 | 0.093 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 8.124853e-01 | 0.090 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.131551e-01 | 0.090 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.131551e-01 | 0.090 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.131551e-01 | 0.090 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.131551e-01 | 0.090 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.131551e-01 | 0.090 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.131551e-01 | 0.090 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.131551e-01 | 0.090 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.131551e-01 | 0.090 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.131551e-01 | 0.090 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.206550e-01 | 0.086 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.206550e-01 | 0.086 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.206550e-01 | 0.086 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.232897e-01 | 0.084 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.235318e-01 | 0.084 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.274311e-01 | 0.082 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.278543e-01 | 0.082 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.278543e-01 | 0.082 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.278543e-01 | 0.082 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.278543e-01 | 0.082 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.278543e-01 | 0.082 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.278543e-01 | 0.082 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.313610e-01 | 0.080 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.347650e-01 | 0.078 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.347650e-01 | 0.078 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.347650e-01 | 0.078 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.347650e-01 | 0.078 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.347650e-01 | 0.078 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.347650e-01 | 0.078 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.347650e-01 | 0.078 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.358173e-01 | 0.078 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.364280e-01 | 0.078 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.382847e-01 | 0.077 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.382847e-01 | 0.077 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.382847e-01 | 0.077 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.401719e-01 | 0.076 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.413987e-01 | 0.075 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.413987e-01 | 0.075 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.413987e-01 | 0.075 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.413987e-01 | 0.075 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.413987e-01 | 0.075 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.413987e-01 | 0.075 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.432965e-01 | 0.074 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.477665e-01 | 0.072 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.477665e-01 | 0.072 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.477665e-01 | 0.072 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.477665e-01 | 0.072 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.485823e-01 | 0.071 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.486562e-01 | 0.071 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.526414e-01 | 0.069 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.528995e-01 | 0.069 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.528995e-01 | 0.069 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.538789e-01 | 0.069 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.538789e-01 | 0.069 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.538789e-01 | 0.069 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.542143e-01 | 0.068 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.566053e-01 | 0.067 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.574971e-01 | 0.067 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.597464e-01 | 0.066 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.597464e-01 | 0.066 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.597464e-01 | 0.066 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.597464e-01 | 0.066 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.597464e-01 | 0.066 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.604757e-01 | 0.065 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.618984e-01 | 0.065 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.642543e-01 | 0.063 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.653785e-01 | 0.063 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.663007e-01 | 0.062 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.663007e-01 | 0.062 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 8.705129e-01 | 0.060 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.707848e-01 | 0.060 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.707848e-01 | 0.060 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.715422e-01 | 0.060 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.736684e-01 | 0.059 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.746028e-01 | 0.058 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.750550e-01 | 0.058 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.759743e-01 | 0.058 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.759743e-01 | 0.058 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.775233e-01 | 0.057 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.785734e-01 | 0.056 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.785734e-01 | 0.056 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.809557e-01 | 0.055 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.809557e-01 | 0.055 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.818260e-01 | 0.055 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.857373e-01 | 0.053 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.857373e-01 | 0.053 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.857373e-01 | 0.053 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.857373e-01 | 0.053 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.857373e-01 | 0.053 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.857373e-01 | 0.053 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.874525e-01 | 0.052 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.897991e-01 | 0.051 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 8.902304e-01 | 0.050 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.903271e-01 | 0.050 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.903271e-01 | 0.050 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.903271e-01 | 0.050 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.903271e-01 | 0.050 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.903271e-01 | 0.050 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.903271e-01 | 0.050 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.903271e-01 | 0.050 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.903271e-01 | 0.050 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.903271e-01 | 0.050 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.947329e-01 | 0.048 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.947329e-01 | 0.048 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 8.947329e-01 | 0.048 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.965186e-01 | 0.047 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 8.973446e-01 | 0.047 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.973446e-01 | 0.047 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.989619e-01 | 0.046 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.017270e-01 | 0.045 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.032720e-01 | 0.044 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.084134e-01 | 0.042 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.106579e-01 | 0.041 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.106579e-01 | 0.041 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.106579e-01 | 0.041 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.113079e-01 | 0.040 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.123504e-01 | 0.040 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.135323e-01 | 0.039 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.135323e-01 | 0.039 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.153662e-01 | 0.038 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.193630e-01 | 0.037 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.206254e-01 | 0.036 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.210018e-01 | 0.036 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.210018e-01 | 0.036 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.232165e-01 | 0.035 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.232165e-01 | 0.035 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.241769e-01 | 0.034 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.243181e-01 | 0.034 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.257277e-01 | 0.034 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.266357e-01 | 0.033 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.272245e-01 | 0.033 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.301498e-01 | 0.031 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.329576e-01 | 0.030 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.329576e-01 | 0.030 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.350181e-01 | 0.029 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.356528e-01 | 0.029 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.356528e-01 | 0.029 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.356528e-01 | 0.029 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.373106e-01 | 0.028 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.381525e-01 | 0.028 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.382398e-01 | 0.028 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.382398e-01 | 0.028 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.382398e-01 | 0.028 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.382398e-01 | 0.028 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.407229e-01 | 0.027 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.407229e-01 | 0.027 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.407229e-01 | 0.027 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.409242e-01 | 0.026 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.424304e-01 | 0.026 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.431064e-01 | 0.025 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.431064e-01 | 0.025 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.431064e-01 | 0.025 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.453941e-01 | 0.024 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.475900e-01 | 0.023 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.475900e-01 | 0.023 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.498631e-01 | 0.022 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.524009e-01 | 0.021 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.535452e-01 | 0.021 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.536626e-01 | 0.021 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.536626e-01 | 0.021 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.538868e-01 | 0.021 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.538868e-01 | 0.021 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.588029e-01 | 0.018 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.590325e-01 | 0.018 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.590325e-01 | 0.018 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.601137e-01 | 0.018 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.606807e-01 | 0.017 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.606807e-01 | 0.017 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.606807e-01 | 0.017 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.612885e-01 | 0.017 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.622626e-01 | 0.017 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.637810e-01 | 0.016 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.652383e-01 | 0.015 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.666372e-01 | 0.015 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.668057e-01 | 0.015 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.671267e-01 | 0.015 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.678163e-01 | 0.014 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.692684e-01 | 0.014 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.703712e-01 | 0.013 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.703712e-01 | 0.013 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.706765e-01 | 0.013 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.716925e-01 | 0.012 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.742203e-01 | 0.011 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.759592e-01 | 0.011 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.759828e-01 | 0.011 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.759828e-01 | 0.011 | 0 | 0 |
| Translation | R-HSA-72766 | 9.764328e-01 | 0.010 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.769498e-01 | 0.010 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.792855e-01 | 0.009 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.809746e-01 | 0.008 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.812319e-01 | 0.008 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.827133e-01 | 0.008 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.830850e-01 | 0.007 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.847195e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.859260e-01 | 0.006 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.875598e-01 | 0.005 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.885423e-01 | 0.005 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.890041e-01 | 0.005 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.891174e-01 | 0.005 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.900920e-01 | 0.004 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.902810e-01 | 0.004 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.906729e-01 | 0.004 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.929613e-01 | 0.003 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.930078e-01 | 0.003 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.931750e-01 | 0.003 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.932899e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.935606e-01 | 0.003 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.962481e-01 | 0.002 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.966923e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.972894e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.973595e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.976762e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.980739e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.982780e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.988603e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.989931e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.990729e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.995012e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.997267e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.997631e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.998368e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.998828e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999201e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999384e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999585e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999662e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999813e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999947e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999948e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999981e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999983e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999996e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 1 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.330669e-16 | 15.477 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.881784e-16 | 15.051 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.221245e-15 | 14.913 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.531308e-14 | 13.597 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.331468e-14 | 13.632 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.839773e-14 | 13.234 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.452172e-13 | 12.838 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.298473e-13 | 12.482 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.262768e-13 | 12.203 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 5.938583e-13 | 12.226 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 9.379164e-13 | 12.028 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.881784e-13 | 12.051 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.065992e-12 | 11.513 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.798628e-12 | 11.420 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.188250e-12 | 11.143 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.525314e-12 | 11.123 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.797185e-12 | 11.056 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.362621e-11 | 10.866 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.433065e-11 | 10.844 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.010547e-11 | 10.697 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.961187e-11 | 10.707 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.355771e-11 | 10.628 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.464984e-11 | 10.608 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.718403e-11 | 10.566 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.061707e-11 | 10.391 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.120482e-11 | 10.147 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.252286e-10 | 9.902 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.003441e-10 | 9.698 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.568162e-10 | 9.590 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.022641e-10 | 9.520 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.582969e-10 | 9.446 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.950112e-10 | 9.403 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.950112e-10 | 9.403 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.026292e-10 | 9.395 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.581071e-10 | 9.253 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.274179e-10 | 9.202 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.396208e-10 | 9.194 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.036178e-09 | 8.985 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.049815e-09 | 8.979 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.117856e-09 | 8.952 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.105994e-09 | 8.956 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.320866e-09 | 8.879 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.840629e-09 | 8.735 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.840629e-09 | 8.735 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.398083e-09 | 8.620 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.684500e-09 | 8.434 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.377566e-09 | 8.359 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.870918e-09 | 8.006 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.920501e-09 | 8.003 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.054375e-08 | 7.977 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.214240e-08 | 7.916 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.253959e-08 | 7.902 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.681666e-08 | 7.774 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.630794e-08 | 7.788 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.968840e-08 | 7.706 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.105326e-08 | 7.677 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.105326e-08 | 7.677 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.408683e-08 | 7.618 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.183836e-08 | 7.497 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.576687e-08 | 7.447 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.978379e-08 | 7.400 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.137400e-08 | 7.383 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.137400e-08 | 7.383 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.852229e-08 | 7.314 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.777940e-08 | 7.321 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.450755e-08 | 7.264 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.454018e-08 | 7.263 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.820565e-08 | 7.166 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.125808e-08 | 7.147 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.322059e-08 | 7.135 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.596771e-08 | 7.119 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.236267e-08 | 7.084 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.470813e-08 | 7.072 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.579026e-08 | 7.067 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.577903e-08 | 7.019 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.108989e-07 | 6.955 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.251408e-07 | 6.903 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.656898e-07 | 6.781 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.027650e-07 | 6.693 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.258505e-07 | 6.646 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.258505e-07 | 6.646 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.258505e-07 | 6.646 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.258505e-07 | 6.646 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.337904e-07 | 6.631 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.522254e-07 | 6.598 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.257967e-07 | 6.487 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.511344e-07 | 6.455 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.361402e-07 | 6.360 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.496411e-07 | 6.347 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.859286e-07 | 6.313 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.347658e-07 | 6.272 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.488577e-07 | 6.261 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.765401e-07 | 6.239 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.779777e-07 | 6.238 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.074715e-07 | 6.216 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.242497e-07 | 6.205 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.405855e-07 | 6.193 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.961405e-07 | 6.099 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.658926e-07 | 6.063 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.037439e-06 | 5.984 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.134830e-06 | 5.945 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.330380e-06 | 5.876 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.405607e-06 | 5.852 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.246437e-06 | 5.489 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.675488e-06 | 5.435 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.844117e-06 | 5.415 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.208400e-06 | 5.376 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.923532e-06 | 5.406 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.420514e-06 | 5.266 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.425408e-06 | 5.266 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.536114e-06 | 5.257 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.802782e-06 | 5.236 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.158785e-06 | 5.088 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.993602e-06 | 5.046 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.993602e-06 | 5.046 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.051916e-06 | 5.043 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.007935e-05 | 4.997 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.131005e-05 | 4.947 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.208660e-05 | 4.918 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.228472e-05 | 4.911 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.263000e-05 | 4.899 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.218942e-05 | 4.654 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.274472e-05 | 4.643 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.437731e-05 | 4.613 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.933879e-05 | 4.533 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.960689e-05 | 4.529 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.312982e-05 | 4.480 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.166005e-05 | 4.499 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.363760e-05 | 4.473 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.676564e-05 | 4.435 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.856449e-05 | 4.414 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.301136e-05 | 4.366 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.413189e-05 | 4.267 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.660061e-05 | 4.247 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.082553e-05 | 4.216 | 0 | 0 |
| Translation | R-HSA-72766 | 6.114099e-05 | 4.214 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.617990e-05 | 4.179 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.804709e-05 | 4.167 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.158262e-05 | 4.145 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.255930e-05 | 4.083 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.255930e-05 | 4.083 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.900959e-05 | 4.051 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.573975e-05 | 4.019 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.027331e-04 | 3.988 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.192257e-04 | 3.924 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.227989e-04 | 3.911 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.356171e-04 | 3.868 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.367106e-04 | 3.864 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.536622e-04 | 3.813 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.623808e-04 | 3.789 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.684077e-04 | 3.774 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.695438e-04 | 3.771 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.699598e-04 | 3.770 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.721348e-04 | 3.764 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.721348e-04 | 3.764 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.802743e-04 | 3.744 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.954605e-04 | 3.709 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.747860e-04 | 3.561 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.747860e-04 | 3.561 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.505634e-04 | 3.601 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.849921e-04 | 3.545 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.934916e-04 | 3.532 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.955449e-04 | 3.529 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.008658e-04 | 3.522 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.016325e-04 | 3.521 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.209049e-04 | 3.494 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.863623e-04 | 3.413 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.892477e-04 | 3.410 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.929487e-04 | 3.406 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.988911e-04 | 3.399 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.260662e-04 | 3.371 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.447674e-04 | 3.352 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.447674e-04 | 3.352 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.582388e-04 | 3.339 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.197311e-04 | 3.284 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.521989e-04 | 3.258 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.708093e-04 | 3.173 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.124356e-04 | 3.213 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.207485e-04 | 3.207 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.734536e-04 | 3.172 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.525498e-04 | 3.069 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.525498e-04 | 3.069 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.037454e-04 | 3.044 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 9.249728e-04 | 3.034 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.259640e-04 | 3.033 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.519281e-04 | 3.021 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.519281e-04 | 3.021 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.940521e-04 | 3.003 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.990659e-04 | 3.000 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.065032e-03 | 2.973 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.090838e-03 | 2.962 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.181021e-03 | 2.928 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.253331e-03 | 2.902 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.281871e-03 | 2.892 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.295678e-03 | 2.888 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.449806e-03 | 2.839 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.463324e-03 | 2.835 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.733128e-03 | 2.761 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.733128e-03 | 2.761 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.619154e-03 | 2.791 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.489167e-03 | 2.827 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.733128e-03 | 2.761 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.762501e-03 | 2.754 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.281585e-03 | 2.642 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.343438e-03 | 2.630 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.403622e-03 | 2.619 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.876696e-03 | 2.541 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.888131e-03 | 2.539 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.977341e-03 | 2.526 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.989356e-03 | 2.524 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.073300e-03 | 2.512 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.210508e-03 | 2.493 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.376494e-03 | 2.472 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.788148e-03 | 2.422 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.872234e-03 | 2.412 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.960728e-03 | 2.402 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.998659e-03 | 2.398 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.101089e-03 | 2.387 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.101251e-03 | 2.387 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.178921e-03 | 2.379 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.289836e-03 | 2.368 | 1 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.292351e-03 | 2.367 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.787871e-03 | 2.320 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.791515e-03 | 2.320 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.931532e-03 | 2.307 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.024897e-03 | 2.299 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.024897e-03 | 2.299 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.904712e-03 | 2.229 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.629304e-03 | 2.250 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.988137e-03 | 2.223 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.988137e-03 | 2.223 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.150351e-03 | 2.211 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.239532e-03 | 2.205 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.643124e-03 | 2.248 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.472038e-03 | 2.189 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.620379e-03 | 2.179 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.692043e-03 | 2.174 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.697545e-03 | 2.114 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.390446e-03 | 2.076 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.658653e-03 | 2.063 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.658653e-03 | 2.063 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.665254e-03 | 2.062 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 8.665254e-03 | 2.062 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.808908e-03 | 2.055 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.808908e-03 | 2.055 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.980522e-03 | 2.047 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.157816e-03 | 2.038 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.470875e-03 | 2.024 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.013058e-02 | 1.994 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.013058e-02 | 1.994 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.013058e-02 | 1.994 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.024081e-02 | 1.990 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.024081e-02 | 1.990 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.024081e-02 | 1.990 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.024081e-02 | 1.990 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.024081e-02 | 1.990 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.024081e-02 | 1.990 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.024081e-02 | 1.990 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.024081e-02 | 1.990 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.024081e-02 | 1.990 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.024081e-02 | 1.990 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.024081e-02 | 1.990 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.037273e-02 | 1.984 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.041966e-02 | 1.982 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.094499e-02 | 1.961 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.096138e-02 | 1.960 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.113117e-02 | 1.953 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.162614e-02 | 1.935 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.175557e-02 | 1.930 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.191881e-02 | 1.924 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.216069e-02 | 1.915 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.353924e-02 | 1.868 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.353924e-02 | 1.868 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.383931e-02 | 1.859 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.757260e-02 | 1.755 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.550969e-02 | 1.809 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.695868e-02 | 1.771 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.567995e-02 | 1.805 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.489209e-02 | 1.827 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.548545e-02 | 1.810 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.759950e-02 | 1.754 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.759950e-02 | 1.754 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.759950e-02 | 1.754 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.804398e-02 | 1.744 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.969225e-02 | 1.706 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.988492e-02 | 1.701 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.988492e-02 | 1.701 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.054869e-02 | 1.687 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.064800e-02 | 1.685 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.185173e-02 | 1.661 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.193492e-02 | 1.659 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.193492e-02 | 1.659 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.193492e-02 | 1.659 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.193492e-02 | 1.659 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.234504e-02 | 1.651 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.451963e-02 | 1.610 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.493457e-02 | 1.603 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.498273e-02 | 1.602 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.661824e-02 | 1.575 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.669918e-02 | 1.574 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.780638e-02 | 1.556 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.913338e-02 | 1.536 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.946532e-02 | 1.531 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.079988e-02 | 1.511 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.079988e-02 | 1.511 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.180059e-02 | 1.498 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.364601e-02 | 1.473 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.396282e-02 | 1.469 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.398271e-02 | 1.469 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.587305e-02 | 1.445 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.587305e-02 | 1.445 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.663065e-02 | 1.436 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.663065e-02 | 1.436 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.663065e-02 | 1.436 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.663065e-02 | 1.436 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.663065e-02 | 1.436 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 3.693455e-02 | 1.433 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.713390e-02 | 1.430 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.713390e-02 | 1.430 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.716205e-02 | 1.430 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.734983e-02 | 1.428 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.761845e-02 | 1.425 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.075546e-02 | 1.390 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.586763e-02 | 1.338 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.586763e-02 | 1.338 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.526967e-02 | 1.258 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.526967e-02 | 1.258 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.526967e-02 | 1.258 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.526967e-02 | 1.258 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.140068e-02 | 1.289 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.266637e-02 | 1.278 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.234312e-02 | 1.373 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.571555e-02 | 1.340 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.125049e-02 | 1.290 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.399083e-02 | 1.357 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.463883e-02 | 1.350 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.409909e-02 | 1.267 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.538940e-02 | 1.343 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.906867e-02 | 1.309 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.125049e-02 | 1.290 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.378874e-02 | 1.269 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.586763e-02 | 1.338 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.266280e-02 | 1.278 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.586763e-02 | 1.338 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.526967e-02 | 1.258 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.526967e-02 | 1.258 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.640433e-02 | 1.333 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.538940e-02 | 1.343 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.878917e-02 | 1.312 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.877957e-02 | 1.312 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.600515e-02 | 1.252 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.982853e-02 | 1.223 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.142566e-02 | 1.212 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.142566e-02 | 1.212 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.142566e-02 | 1.212 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.282941e-02 | 1.202 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.324724e-02 | 1.199 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.324724e-02 | 1.199 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.324724e-02 | 1.199 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.335490e-02 | 1.198 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.527892e-02 | 1.185 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.527892e-02 | 1.185 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.527892e-02 | 1.185 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.527892e-02 | 1.185 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.527892e-02 | 1.185 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.527892e-02 | 1.185 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.527892e-02 | 1.185 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.692088e-02 | 1.174 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.692088e-02 | 1.174 | 1 | 1 |
| Signaling by NOTCH | R-HSA-157118 | 7.108731e-02 | 1.148 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.236829e-02 | 1.140 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 7.250711e-02 | 1.140 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 7.250711e-02 | 1.140 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 7.250711e-02 | 1.140 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 7.250711e-02 | 1.140 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 7.250711e-02 | 1.140 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 7.250711e-02 | 1.140 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 7.250711e-02 | 1.140 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.332260e-02 | 1.135 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.373586e-02 | 1.132 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.583787e-02 | 1.120 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 7.583787e-02 | 1.120 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 7.583787e-02 | 1.120 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.583787e-02 | 1.120 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.583787e-02 | 1.120 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.583787e-02 | 1.120 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.583787e-02 | 1.120 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.583787e-02 | 1.120 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.583787e-02 | 1.120 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.590775e-02 | 1.120 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.705763e-02 | 1.113 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.854486e-02 | 1.105 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.924679e-02 | 1.101 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.108413e-02 | 1.091 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.108413e-02 | 1.091 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.108413e-02 | 1.091 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.108413e-02 | 1.091 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.285974e-02 | 1.082 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.312915e-02 | 1.080 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.312915e-02 | 1.080 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.312915e-02 | 1.080 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.402669e-02 | 1.076 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.404842e-02 | 1.075 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.404842e-02 | 1.075 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.448907e-02 | 1.073 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.685502e-02 | 1.061 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.689240e-02 | 1.061 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.689240e-02 | 1.061 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.689240e-02 | 1.061 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.067678e-01 | 0.972 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.067678e-01 | 0.972 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.067678e-01 | 0.972 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.067678e-01 | 0.972 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.102878e-01 | 0.957 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.102878e-01 | 0.957 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.350940e-01 | 0.869 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.350940e-01 | 0.869 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.131845e-01 | 0.946 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.295460e-01 | 0.888 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.295460e-01 | 0.888 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.295460e-01 | 0.888 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.761936e-02 | 1.010 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.034551e-01 | 0.985 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.034551e-01 | 0.985 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.034551e-01 | 0.985 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.034551e-01 | 0.985 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.230236e-02 | 1.035 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.768391e-02 | 1.010 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 1.295460e-01 | 0.888 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 1.131845e-01 | 0.946 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.112809e-01 | 0.954 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.102878e-01 | 0.957 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.225360e-01 | 0.912 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.034551e-01 | 0.985 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.270416e-01 | 0.896 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.348866e-01 | 0.870 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.169410e-01 | 0.932 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.218803e-01 | 0.914 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.102878e-01 | 0.957 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.028310e-02 | 1.044 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.167836e-01 | 0.933 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.032765e-01 | 0.986 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.350940e-01 | 0.869 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.761936e-02 | 1.010 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.053212e-01 | 0.977 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.348866e-01 | 0.870 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.348866e-01 | 0.870 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.028063e-02 | 1.044 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.067678e-01 | 0.972 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 9.839163e-02 | 1.007 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.053212e-01 | 0.977 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.193630e-02 | 1.037 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.069941e-01 | 0.971 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.032048e-01 | 0.986 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.750898e-02 | 1.011 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.102878e-01 | 0.957 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.225650e-01 | 0.912 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.208608e-01 | 0.918 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.218803e-01 | 0.914 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.283141e-01 | 0.892 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.272448e-01 | 0.895 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.283141e-01 | 0.892 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.131845e-01 | 0.946 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.761936e-02 | 1.010 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.350940e-01 | 0.869 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.177866e-01 | 0.929 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.761936e-02 | 1.010 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 1.380223e-01 | 0.860 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.380223e-01 | 0.860 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.380223e-01 | 0.860 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.380223e-01 | 0.860 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.389378e-01 | 0.857 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.397650e-01 | 0.855 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.397650e-01 | 0.855 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.397650e-01 | 0.855 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 1.397650e-01 | 0.855 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.397650e-01 | 0.855 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.397650e-01 | 0.855 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.415931e-01 | 0.849 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.415931e-01 | 0.849 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.417908e-01 | 0.848 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.466812e-01 | 0.834 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.468127e-01 | 0.833 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.479225e-01 | 0.830 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 1.479225e-01 | 0.830 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 1.479225e-01 | 0.830 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 1.479225e-01 | 0.830 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.479225e-01 | 0.830 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.479225e-01 | 0.830 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.484289e-01 | 0.828 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.484289e-01 | 0.828 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.484289e-01 | 0.828 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.534527e-01 | 0.814 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.554050e-01 | 0.809 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.554050e-01 | 0.809 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.555117e-01 | 0.808 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.556168e-01 | 0.808 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.609843e-01 | 0.793 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.609843e-01 | 0.793 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.609843e-01 | 0.793 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.609843e-01 | 0.793 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.609843e-01 | 0.793 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.609843e-01 | 0.793 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.609843e-01 | 0.793 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.624691e-01 | 0.789 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.663829e-01 | 0.779 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.715451e-01 | 0.766 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.021531e-01 | 0.694 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.021531e-01 | 0.694 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.316320e-01 | 0.635 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.316320e-01 | 0.635 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.316320e-01 | 0.635 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.600234e-01 | 0.585 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.600234e-01 | 0.585 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.600234e-01 | 0.585 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.600234e-01 | 0.585 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.600234e-01 | 0.585 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.600234e-01 | 0.585 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.873674e-01 | 0.542 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.873674e-01 | 0.542 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.873674e-01 | 0.542 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 2.873674e-01 | 0.542 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.873674e-01 | 0.542 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.742449e-01 | 0.759 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.137027e-01 | 0.503 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.137027e-01 | 0.503 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.137027e-01 | 0.503 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.137027e-01 | 0.503 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.876718e-01 | 0.727 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.390662e-01 | 0.470 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.390662e-01 | 0.470 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.390662e-01 | 0.470 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.390662e-01 | 0.470 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.390662e-01 | 0.470 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.149052e-01 | 0.668 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.286570e-01 | 0.641 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.424656e-01 | 0.615 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.018587e-01 | 0.695 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.114929e-01 | 0.675 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.840102e-01 | 0.547 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.978321e-01 | 0.526 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.978321e-01 | 0.526 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.116114e-01 | 0.506 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 3.253325e-01 | 0.488 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 3.253325e-01 | 0.488 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 3.253325e-01 | 0.488 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.228073e-01 | 0.652 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.924983e-01 | 0.716 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.387318e-01 | 0.622 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 2.912748e-01 | 0.536 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.467919e-01 | 0.608 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.467919e-01 | 0.608 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.530760e-01 | 0.597 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.213825e-01 | 0.493 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.775582e-01 | 0.557 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.775582e-01 | 0.557 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 2.912748e-01 | 0.536 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.365740e-01 | 0.626 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.603725e-01 | 0.584 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 3.389807e-01 | 0.470 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.775582e-01 | 0.557 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.149052e-01 | 0.668 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.149532e-01 | 0.668 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.989650e-01 | 0.701 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 2.563079e-01 | 0.591 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.582714e-01 | 0.588 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.738775e-01 | 0.562 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.738775e-01 | 0.562 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.394822e-01 | 0.469 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 1.736437e-01 | 0.760 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.018587e-01 | 0.695 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.409415e-01 | 0.618 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.382524e-01 | 0.471 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.701627e-01 | 0.568 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.609326e-01 | 0.583 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.042377e-01 | 0.690 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.316320e-01 | 0.635 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.137027e-01 | 0.503 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.149052e-01 | 0.668 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.912748e-01 | 0.536 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 2.316320e-01 | 0.635 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.316320e-01 | 0.635 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.600234e-01 | 0.585 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 3.390662e-01 | 0.470 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.067956e-01 | 0.513 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.802310e-01 | 0.552 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.288753e-01 | 0.483 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.424656e-01 | 0.615 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.018587e-01 | 0.695 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.102820e-01 | 0.508 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.450527e-01 | 0.462 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.021531e-01 | 0.694 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.316320e-01 | 0.635 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.316320e-01 | 0.635 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.600234e-01 | 0.585 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.600234e-01 | 0.585 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.137027e-01 | 0.503 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.390662e-01 | 0.470 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.149052e-01 | 0.668 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.424656e-01 | 0.615 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 2.563079e-01 | 0.591 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.218417e-01 | 0.492 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.298115e-01 | 0.482 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.878958e-01 | 0.726 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.735682e-01 | 0.761 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.075254e-01 | 0.683 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.116411e-01 | 0.506 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.467008e-01 | 0.460 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.467008e-01 | 0.460 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.490909e-01 | 0.604 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.316320e-01 | 0.635 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.390662e-01 | 0.470 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 1.876718e-01 | 0.727 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.840102e-01 | 0.547 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.775582e-01 | 0.557 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.286570e-01 | 0.641 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.509074e-01 | 0.600 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.918842e-01 | 0.717 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.389807e-01 | 0.470 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.101632e-01 | 0.677 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.021531e-01 | 0.694 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.600234e-01 | 0.585 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.742449e-01 | 0.759 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.137027e-01 | 0.503 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.137027e-01 | 0.503 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.563079e-01 | 0.591 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 3.116114e-01 | 0.506 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.509074e-01 | 0.600 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.055049e-01 | 0.687 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.253325e-01 | 0.488 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.488383e-01 | 0.604 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.422411e-01 | 0.466 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 1.876718e-01 | 0.727 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.829237e-01 | 0.738 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.014495e-01 | 0.521 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.467008e-01 | 0.460 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.840102e-01 | 0.547 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.021531e-01 | 0.694 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.316320e-01 | 0.635 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.316320e-01 | 0.635 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.600234e-01 | 0.585 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.873674e-01 | 0.542 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.742449e-01 | 0.759 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.137027e-01 | 0.503 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.390662e-01 | 0.470 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 2.010082e-01 | 0.697 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.014495e-01 | 0.521 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.409415e-01 | 0.618 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.829237e-01 | 0.738 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.218417e-01 | 0.492 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 2.866177e-01 | 0.543 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.736437e-01 | 0.760 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.310441e-01 | 0.636 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.409415e-01 | 0.618 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.173495e-01 | 0.498 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.600234e-01 | 0.585 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 2.873674e-01 | 0.542 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.742449e-01 | 0.759 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.137027e-01 | 0.503 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.424656e-01 | 0.615 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.424656e-01 | 0.615 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.736437e-01 | 0.760 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.149052e-01 | 0.668 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.424656e-01 | 0.615 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.936432e-01 | 0.713 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.742513e-01 | 0.562 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.775705e-01 | 0.751 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.735682e-01 | 0.761 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 2.349241e-01 | 0.629 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.630827e-01 | 0.580 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.840102e-01 | 0.547 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.409415e-01 | 0.618 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.324637e-01 | 0.634 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.428679e-01 | 0.465 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.253325e-01 | 0.488 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.876718e-01 | 0.727 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.001182e-01 | 0.523 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.063903e-01 | 0.514 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.276001e-01 | 0.643 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.563079e-01 | 0.591 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.978321e-01 | 0.526 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 3.399490e-01 | 0.469 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.245028e-01 | 0.649 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 3.320441e-01 | 0.479 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.390662e-01 | 0.470 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.012346e-01 | 0.696 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.286570e-01 | 0.641 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.701627e-01 | 0.568 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.386457e-01 | 0.470 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.390662e-01 | 0.470 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 2.286570e-01 | 0.641 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 1.876718e-01 | 0.727 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.756250e-01 | 0.755 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.978321e-01 | 0.526 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.912748e-01 | 0.536 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.912748e-01 | 0.536 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.018587e-01 | 0.695 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.524257e-01 | 0.453 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.525429e-01 | 0.453 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.525429e-01 | 0.453 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.525429e-01 | 0.453 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.525429e-01 | 0.453 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.542734e-01 | 0.451 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.546739e-01 | 0.450 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.551527e-01 | 0.450 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.562265e-01 | 0.448 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.562297e-01 | 0.448 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.634939e-01 | 0.440 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.634939e-01 | 0.440 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.634939e-01 | 0.440 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.634939e-01 | 0.440 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.634939e-01 | 0.440 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.634939e-01 | 0.440 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.634939e-01 | 0.440 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.636040e-01 | 0.439 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.660068e-01 | 0.437 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.660068e-01 | 0.437 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.660068e-01 | 0.437 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.660068e-01 | 0.437 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.660068e-01 | 0.437 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.660068e-01 | 0.437 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.727318e-01 | 0.429 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.783161e-01 | 0.422 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.789044e-01 | 0.421 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.789044e-01 | 0.421 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.789044e-01 | 0.421 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.793610e-01 | 0.421 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.793610e-01 | 0.421 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.793610e-01 | 0.421 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.793610e-01 | 0.421 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.793610e-01 | 0.421 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.804891e-01 | 0.420 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.828409e-01 | 0.417 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.828409e-01 | 0.417 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.828409e-01 | 0.417 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 3.828409e-01 | 0.417 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.832457e-01 | 0.417 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.870201e-01 | 0.412 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.870201e-01 | 0.412 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.870201e-01 | 0.412 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.870201e-01 | 0.412 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.870201e-01 | 0.412 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 3.870201e-01 | 0.412 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.870201e-01 | 0.412 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.870201e-01 | 0.412 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.870201e-01 | 0.412 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.870201e-01 | 0.412 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 3.870201e-01 | 0.412 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.870201e-01 | 0.412 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.870201e-01 | 0.412 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.870201e-01 | 0.412 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.911428e-01 | 0.408 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.925955e-01 | 0.406 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.925955e-01 | 0.406 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.925955e-01 | 0.406 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.925955e-01 | 0.406 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.925955e-01 | 0.406 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.929128e-01 | 0.406 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.929128e-01 | 0.406 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.929128e-01 | 0.406 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.929128e-01 | 0.406 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.929128e-01 | 0.406 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.990920e-01 | 0.399 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.029419e-01 | 0.395 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.057007e-01 | 0.392 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.057007e-01 | 0.392 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.057007e-01 | 0.392 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 4.057007e-01 | 0.392 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.057175e-01 | 0.392 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.057175e-01 | 0.392 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.072087e-01 | 0.390 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.096782e-01 | 0.388 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.096782e-01 | 0.388 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.096782e-01 | 0.388 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.096782e-01 | 0.388 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.096782e-01 | 0.388 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.096782e-01 | 0.388 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.096782e-01 | 0.388 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.096782e-01 | 0.388 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.096782e-01 | 0.388 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.096782e-01 | 0.388 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.096782e-01 | 0.388 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.096782e-01 | 0.388 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.096782e-01 | 0.388 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.096782e-01 | 0.388 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.096782e-01 | 0.388 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.096782e-01 | 0.388 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.129231e-01 | 0.384 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.186682e-01 | 0.378 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.214049e-01 | 0.375 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.224291e-01 | 0.374 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.224291e-01 | 0.374 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.237888e-01 | 0.373 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.314903e-01 | 0.365 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.314903e-01 | 0.365 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.314903e-01 | 0.365 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.314903e-01 | 0.365 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.314903e-01 | 0.365 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.314903e-01 | 0.365 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.315001e-01 | 0.365 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.315001e-01 | 0.365 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.315001e-01 | 0.365 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.315001e-01 | 0.365 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.315001e-01 | 0.365 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.315001e-01 | 0.365 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.315001e-01 | 0.365 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.315001e-01 | 0.365 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.315001e-01 | 0.365 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.315001e-01 | 0.365 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.315001e-01 | 0.365 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.315001e-01 | 0.365 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.327213e-01 | 0.364 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.335146e-01 | 0.363 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.351493e-01 | 0.361 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.425291e-01 | 0.354 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.441600e-01 | 0.352 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.441600e-01 | 0.352 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 4.441600e-01 | 0.352 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.441600e-01 | 0.352 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.496786e-01 | 0.347 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.522701e-01 | 0.345 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.525166e-01 | 0.344 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.525166e-01 | 0.344 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.525166e-01 | 0.344 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.525166e-01 | 0.344 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.525166e-01 | 0.344 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.525166e-01 | 0.344 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.525166e-01 | 0.344 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.525166e-01 | 0.344 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 4.525166e-01 | 0.344 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 4.525166e-01 | 0.344 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 4.525166e-01 | 0.344 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.525166e-01 | 0.344 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.525166e-01 | 0.344 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.525166e-01 | 0.344 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.525166e-01 | 0.344 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.525166e-01 | 0.344 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.525166e-01 | 0.344 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.525166e-01 | 0.344 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.525166e-01 | 0.344 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.525166e-01 | 0.344 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.525166e-01 | 0.344 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.525166e-01 | 0.344 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.566711e-01 | 0.340 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 4.566711e-01 | 0.340 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.566711e-01 | 0.340 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.566711e-01 | 0.340 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.566711e-01 | 0.340 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.619404e-01 | 0.335 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.619404e-01 | 0.335 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.636139e-01 | 0.334 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 4.636139e-01 | 0.334 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.690180e-01 | 0.329 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.690180e-01 | 0.329 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.690180e-01 | 0.329 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.712825e-01 | 0.327 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.712825e-01 | 0.327 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 4.715359e-01 | 0.326 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.727574e-01 | 0.325 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.727574e-01 | 0.325 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.727574e-01 | 0.325 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.727574e-01 | 0.325 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.727574e-01 | 0.325 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.727574e-01 | 0.325 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.727574e-01 | 0.325 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.727574e-01 | 0.325 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.784253e-01 | 0.320 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.798476e-01 | 0.319 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 4.798476e-01 | 0.319 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.810532e-01 | 0.318 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.810532e-01 | 0.318 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.811958e-01 | 0.318 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.811958e-01 | 0.318 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.811958e-01 | 0.318 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.811958e-01 | 0.318 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.811958e-01 | 0.318 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.811958e-01 | 0.318 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.811958e-01 | 0.318 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.811958e-01 | 0.318 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.855357e-01 | 0.314 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.855357e-01 | 0.314 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.904888e-01 | 0.309 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.904888e-01 | 0.309 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.904888e-01 | 0.309 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.922511e-01 | 0.308 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.922511e-01 | 0.308 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.922511e-01 | 0.308 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 4.922511e-01 | 0.308 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.922511e-01 | 0.308 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 4.922511e-01 | 0.308 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 4.922511e-01 | 0.308 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.922511e-01 | 0.308 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 4.922511e-01 | 0.308 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.922511e-01 | 0.308 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.922511e-01 | 0.308 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.932000e-01 | 0.307 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.932000e-01 | 0.307 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.932000e-01 | 0.307 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.996521e-01 | 0.301 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.050270e-01 | 0.297 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.050270e-01 | 0.297 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.050913e-01 | 0.297 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.066548e-01 | 0.295 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.091023e-01 | 0.293 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.110251e-01 | 0.292 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.110251e-01 | 0.292 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.110251e-01 | 0.292 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.110251e-01 | 0.292 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.110251e-01 | 0.292 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.110251e-01 | 0.292 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.110251e-01 | 0.292 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.110251e-01 | 0.292 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.110251e-01 | 0.292 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 5.110251e-01 | 0.292 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.110251e-01 | 0.292 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.110251e-01 | 0.292 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.110251e-01 | 0.292 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.110251e-01 | 0.292 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.110251e-01 | 0.292 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.110251e-01 | 0.292 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.110251e-01 | 0.292 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.116503e-01 | 0.291 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.152812e-01 | 0.288 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.166733e-01 | 0.287 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.166733e-01 | 0.287 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.182744e-01 | 0.285 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.205410e-01 | 0.284 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.274215e-01 | 0.278 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.274215e-01 | 0.278 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.281362e-01 | 0.277 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.281362e-01 | 0.277 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.281362e-01 | 0.277 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.281362e-01 | 0.277 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.281362e-01 | 0.277 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.281362e-01 | 0.277 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.291061e-01 | 0.276 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.291061e-01 | 0.276 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.291061e-01 | 0.276 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.291061e-01 | 0.276 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.291061e-01 | 0.276 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.291061e-01 | 0.276 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.291061e-01 | 0.276 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.291061e-01 | 0.276 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.291061e-01 | 0.276 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.291061e-01 | 0.276 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.291061e-01 | 0.276 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.291061e-01 | 0.276 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.291061e-01 | 0.276 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.394133e-01 | 0.268 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 5.394133e-01 | 0.268 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.394133e-01 | 0.268 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.452220e-01 | 0.263 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.465196e-01 | 0.262 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.465196e-01 | 0.262 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.465196e-01 | 0.262 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 5.465196e-01 | 0.262 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 5.465196e-01 | 0.262 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 5.465196e-01 | 0.262 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.465196e-01 | 0.262 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.477953e-01 | 0.261 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 5.501022e-01 | 0.260 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.505027e-01 | 0.259 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.505027e-01 | 0.259 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.505027e-01 | 0.259 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.576007e-01 | 0.254 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.585422e-01 | 0.253 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.600352e-01 | 0.252 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.611416e-01 | 0.251 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.611416e-01 | 0.251 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.614029e-01 | 0.251 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.626912e-01 | 0.250 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.632902e-01 | 0.249 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.632902e-01 | 0.249 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.632902e-01 | 0.249 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.686356e-01 | 0.245 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.721126e-01 | 0.243 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.721126e-01 | 0.243 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.723936e-01 | 0.242 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.742877e-01 | 0.241 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.794415e-01 | 0.237 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.794415e-01 | 0.237 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.794415e-01 | 0.237 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.794415e-01 | 0.237 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.794415e-01 | 0.237 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.800179e-01 | 0.237 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.800179e-01 | 0.237 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.807830e-01 | 0.236 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.807830e-01 | 0.236 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.826311e-01 | 0.235 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 5.826311e-01 | 0.235 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.826311e-01 | 0.235 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.826311e-01 | 0.235 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.869053e-01 | 0.231 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.869053e-01 | 0.231 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.869053e-01 | 0.231 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.869053e-01 | 0.231 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.929579e-01 | 0.227 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.929579e-01 | 0.227 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.929579e-01 | 0.227 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 5.929579e-01 | 0.227 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 5.929579e-01 | 0.227 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.929579e-01 | 0.227 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 5.936129e-01 | 0.226 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.941334e-01 | 0.226 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.949965e-01 | 0.225 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.949965e-01 | 0.225 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.949965e-01 | 0.225 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 5.949965e-01 | 0.225 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.949965e-01 | 0.225 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 5.949965e-01 | 0.225 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.949965e-01 | 0.225 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.949965e-01 | 0.225 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.949965e-01 | 0.225 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.949965e-01 | 0.225 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.949965e-01 | 0.225 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.949965e-01 | 0.225 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.949965e-01 | 0.225 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.963769e-01 | 0.224 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.965794e-01 | 0.224 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.030927e-01 | 0.220 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.030927e-01 | 0.220 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.030927e-01 | 0.220 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.045294e-01 | 0.219 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.081255e-01 | 0.216 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.099770e-01 | 0.215 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.099770e-01 | 0.215 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.099770e-01 | 0.215 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.099770e-01 | 0.215 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.099770e-01 | 0.215 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.099770e-01 | 0.215 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.099770e-01 | 0.215 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.130356e-01 | 0.213 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.168880e-01 | 0.210 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.169982e-01 | 0.210 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.227870e-01 | 0.206 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.244043e-01 | 0.205 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.244043e-01 | 0.205 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.244043e-01 | 0.205 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.244043e-01 | 0.205 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.244043e-01 | 0.205 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.244043e-01 | 0.205 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.244043e-01 | 0.205 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.244043e-01 | 0.205 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.244043e-01 | 0.205 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.247099e-01 | 0.204 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 6.263803e-01 | 0.203 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.283258e-01 | 0.202 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.323474e-01 | 0.199 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.323474e-01 | 0.199 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.323474e-01 | 0.199 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.382988e-01 | 0.195 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.382988e-01 | 0.195 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.382988e-01 | 0.195 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.382988e-01 | 0.195 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.382988e-01 | 0.195 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.382988e-01 | 0.195 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.382988e-01 | 0.195 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.382988e-01 | 0.195 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.382988e-01 | 0.195 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.382988e-01 | 0.195 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.382988e-01 | 0.195 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.417176e-01 | 0.193 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.435330e-01 | 0.191 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.445324e-01 | 0.191 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.498812e-01 | 0.187 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.511172e-01 | 0.186 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.516801e-01 | 0.186 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.516801e-01 | 0.186 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.516801e-01 | 0.186 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.516801e-01 | 0.186 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 6.516801e-01 | 0.186 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.516801e-01 | 0.186 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.516801e-01 | 0.186 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.516801e-01 | 0.186 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.516801e-01 | 0.186 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.598914e-01 | 0.181 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.598914e-01 | 0.181 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.598914e-01 | 0.181 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.645671e-01 | 0.177 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.645671e-01 | 0.177 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.645671e-01 | 0.177 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.645671e-01 | 0.177 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.686975e-01 | 0.175 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.686975e-01 | 0.175 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 6.686975e-01 | 0.175 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.686975e-01 | 0.175 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.728943e-01 | 0.172 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.761829e-01 | 0.170 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 6.769781e-01 | 0.169 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.769781e-01 | 0.169 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 6.769781e-01 | 0.169 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.769781e-01 | 0.169 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.769781e-01 | 0.169 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.769781e-01 | 0.169 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.769781e-01 | 0.169 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.769781e-01 | 0.169 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.769781e-01 | 0.169 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.773185e-01 | 0.169 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.828465e-01 | 0.166 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.857559e-01 | 0.164 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.857559e-01 | 0.164 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.868480e-01 | 0.163 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.868480e-01 | 0.163 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.868480e-01 | 0.163 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.889306e-01 | 0.162 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.889306e-01 | 0.162 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.889306e-01 | 0.162 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.889306e-01 | 0.162 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 6.889306e-01 | 0.162 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.889306e-01 | 0.162 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.940115e-01 | 0.159 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.940115e-01 | 0.159 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.940115e-01 | 0.159 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.940115e-01 | 0.159 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.985360e-01 | 0.156 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.004416e-01 | 0.155 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.004416e-01 | 0.155 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.004416e-01 | 0.155 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.004416e-01 | 0.155 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.004416e-01 | 0.155 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 7.004416e-01 | 0.155 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.004416e-01 | 0.155 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.004416e-01 | 0.155 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.004416e-01 | 0.155 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 7.020872e-01 | 0.154 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.020872e-01 | 0.154 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.115272e-01 | 0.148 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.115272e-01 | 0.148 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.115272e-01 | 0.148 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.115272e-01 | 0.148 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.115272e-01 | 0.148 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.115272e-01 | 0.148 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.115272e-01 | 0.148 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.115272e-01 | 0.148 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.177070e-01 | 0.144 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.177070e-01 | 0.144 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 7.197703e-01 | 0.143 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.197703e-01 | 0.143 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.222033e-01 | 0.141 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.222033e-01 | 0.141 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.222033e-01 | 0.141 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.252553e-01 | 0.140 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.260220e-01 | 0.139 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 7.324849e-01 | 0.135 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.324849e-01 | 0.135 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.324849e-01 | 0.135 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.324849e-01 | 0.135 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.324849e-01 | 0.135 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.326324e-01 | 0.135 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.326324e-01 | 0.135 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.326324e-01 | 0.135 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.368613e-01 | 0.133 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.423866e-01 | 0.129 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.423866e-01 | 0.129 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.423866e-01 | 0.129 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.423866e-01 | 0.129 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.423866e-01 | 0.129 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.423866e-01 | 0.129 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.423866e-01 | 0.129 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.441226e-01 | 0.128 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.468819e-01 | 0.127 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.472714e-01 | 0.127 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.480805e-01 | 0.126 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.519224e-01 | 0.124 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.519224e-01 | 0.124 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.519224e-01 | 0.124 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.519224e-01 | 0.124 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.519224e-01 | 0.124 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.537591e-01 | 0.123 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.537591e-01 | 0.123 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.572284e-01 | 0.121 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.604748e-01 | 0.119 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.611057e-01 | 0.119 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.611057e-01 | 0.119 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.661254e-01 | 0.116 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 7.667595e-01 | 0.115 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.699496e-01 | 0.114 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.699496e-01 | 0.114 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.699496e-01 | 0.114 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 7.699496e-01 | 0.114 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.721574e-01 | 0.112 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.747735e-01 | 0.111 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.784667e-01 | 0.109 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.784667e-01 | 0.109 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.784667e-01 | 0.109 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.784667e-01 | 0.109 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.784667e-01 | 0.109 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 7.796772e-01 | 0.108 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.826466e-01 | 0.106 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.866689e-01 | 0.104 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.866689e-01 | 0.104 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.866689e-01 | 0.104 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.866689e-01 | 0.104 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 7.866689e-01 | 0.104 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.877400e-01 | 0.104 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.877400e-01 | 0.104 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.917177e-01 | 0.101 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.917177e-01 | 0.101 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.945679e-01 | 0.100 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.945679e-01 | 0.100 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.945679e-01 | 0.100 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.945679e-01 | 0.100 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 7.945679e-01 | 0.100 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.945679e-01 | 0.100 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.953203e-01 | 0.099 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.975176e-01 | 0.098 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.975176e-01 | 0.098 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.021749e-01 | 0.096 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.021749e-01 | 0.096 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.021749e-01 | 0.096 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.021749e-01 | 0.096 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.031741e-01 | 0.095 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.031741e-01 | 0.095 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.086899e-01 | 0.092 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.086899e-01 | 0.092 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.086899e-01 | 0.092 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.095007e-01 | 0.092 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.095007e-01 | 0.092 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.095007e-01 | 0.092 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.095007e-01 | 0.092 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.095007e-01 | 0.092 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.095007e-01 | 0.092 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.140676e-01 | 0.089 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.165556e-01 | 0.088 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.165556e-01 | 0.088 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.233497e-01 | 0.084 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.233497e-01 | 0.084 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.233497e-01 | 0.084 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.233497e-01 | 0.084 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.233497e-01 | 0.084 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.244193e-01 | 0.084 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.293987e-01 | 0.081 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.298926e-01 | 0.081 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.298926e-01 | 0.081 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.298926e-01 | 0.081 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.298926e-01 | 0.081 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.298926e-01 | 0.081 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 8.298926e-01 | 0.081 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.298926e-01 | 0.081 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.298926e-01 | 0.081 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.298926e-01 | 0.081 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.342505e-01 | 0.079 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.361934e-01 | 0.078 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.361934e-01 | 0.078 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.361934e-01 | 0.078 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.361934e-01 | 0.078 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.422613e-01 | 0.075 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.422613e-01 | 0.075 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.422613e-01 | 0.075 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.422613e-01 | 0.075 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.422613e-01 | 0.075 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.422613e-01 | 0.075 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.422613e-01 | 0.075 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.422613e-01 | 0.075 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.481048e-01 | 0.072 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.481048e-01 | 0.072 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.481048e-01 | 0.072 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.481985e-01 | 0.072 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.481985e-01 | 0.072 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.498669e-01 | 0.071 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.585299e-01 | 0.066 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.591513e-01 | 0.066 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 8.636097e-01 | 0.064 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 8.636097e-01 | 0.064 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.643700e-01 | 0.063 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.643700e-01 | 0.063 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.643700e-01 | 0.063 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.643700e-01 | 0.063 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.643700e-01 | 0.063 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.643700e-01 | 0.063 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.643700e-01 | 0.063 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.693957e-01 | 0.061 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.693957e-01 | 0.061 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.693957e-01 | 0.061 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.723044e-01 | 0.059 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.726021e-01 | 0.059 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.742354e-01 | 0.058 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.766372e-01 | 0.057 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.788961e-01 | 0.056 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.788961e-01 | 0.056 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.788961e-01 | 0.056 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.833843e-01 | 0.054 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.833843e-01 | 0.054 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 8.868762e-01 | 0.052 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.877065e-01 | 0.052 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.940839e-01 | 0.049 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.965938e-01 | 0.047 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.965938e-01 | 0.047 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 8.996566e-01 | 0.046 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.997368e-01 | 0.046 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.055302e-01 | 0.043 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.104801e-01 | 0.041 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.104801e-01 | 0.041 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.104801e-01 | 0.041 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.110813e-01 | 0.040 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.110813e-01 | 0.040 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.145597e-01 | 0.039 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.168051e-01 | 0.038 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.169959e-01 | 0.038 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.188377e-01 | 0.037 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.200740e-01 | 0.036 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.230381e-01 | 0.035 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.230381e-01 | 0.035 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.258925e-01 | 0.033 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.258925e-01 | 0.033 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.258925e-01 | 0.033 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.272541e-01 | 0.033 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.286412e-01 | 0.032 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.286412e-01 | 0.032 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.312881e-01 | 0.031 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.324806e-01 | 0.030 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.384597e-01 | 0.028 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.396956e-01 | 0.027 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.403387e-01 | 0.027 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.409310e-01 | 0.026 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.409310e-01 | 0.026 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.456540e-01 | 0.024 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.473234e-01 | 0.024 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.475836e-01 | 0.023 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.487294e-01 | 0.023 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.492226e-01 | 0.023 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.563519e-01 | 0.019 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.577119e-01 | 0.019 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.595325e-01 | 0.018 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.603740e-01 | 0.018 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.608413e-01 | 0.017 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.624816e-01 | 0.017 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.624816e-01 | 0.017 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.624816e-01 | 0.017 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.677518e-01 | 0.014 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.692124e-01 | 0.014 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.701573e-01 | 0.013 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.709832e-01 | 0.013 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.721801e-01 | 0.012 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.722827e-01 | 0.012 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.725594e-01 | 0.012 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.733971e-01 | 0.012 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.741533e-01 | 0.011 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.754024e-01 | 0.011 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.787362e-01 | 0.009 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.859831e-01 | 0.006 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.867361e-01 | 0.006 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.870203e-01 | 0.006 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.871643e-01 | 0.006 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.935300e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.943538e-01 | 0.002 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.951007e-01 | 0.002 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.955866e-01 | 0.002 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.962570e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.968021e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.984850e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.985637e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.986689e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.987049e-01 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.991955e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.995417e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.997603e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997779e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.998886e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999173e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999443e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999460e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999612e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999879e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999946e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999979e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999986e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |